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Abstract: Summary Protein ADP-ribosylation is a post-translational modification (PTM) that consists
of the addition of ADP-ribose moieties to target proteins. In the nucleus, the modification is catalyzed
by members of the diphtheria toxin-like ADP-ribosyl- transferases (ARTDs), of which ARTD1 is the
nuclear most abundant and best studied. ADP-ribosylation has been implicated in a variety of cellular
processes, ranging from maintenance of genome integrity and DNA repair and gene transcription. How-
ever, very little is known about the localization and molecular function of chromatin-associated ADP-
ribosylation. In this thesis, we have investigated the mechanistic role of ARTD1-mediated chromatin
poly-ADP-ribosylation (PARylation) for different cellular conditions. In the first paradigm, we investi-
gated the role of ADP-ribosylation for the transcription of SRY (sex determining region Y)-box 2 (SOX2)
target genes during the early phase of fibroblasts reprogramming to induced pluripotent stem cells (iPSC).
We could show that ARTD1 and PARylation are necessary for iPS colony formation and that PAR forma-
tion keeps SOX2 associated to the DNA to efficiently transcribe SOX2 target genes, including fibroblast
growth factor 4 (Fgf4). We found that exogenous FGF4 administration functionally rescues ARTD1 abla-
tion or inhibition of PARylation. In addition, we have developed a novel chromatin affinity precipitation
(ChAP) protocol to enrich ADP-ribosylated chromatin for elucidating where ADP- ribosylation is local-
ized. We have applied this protocol to an oxidative stress paradigm and found that ADP-ribosylation
induced by hydrogen peroxide (H2O2) preferentially localizes to ARTD1 and nucleosome-dense hete-
rochromatic regions, as well as to repetitive elements within the genome. Chromatin ADP-ribosylation
induced at these sites was correlated with a higher accessibility. Moreover during in vitro induced adipoge-
nesis, ADP-ribosylation was tightly associated with peroxisome proliferator-activated receptor (PPAR￿)
at PPAR￿ target genes. Together, the thesis reveals that chromatin-associated ADP-ribosylation is a
PTM whose induction and genomic distribution varies with the stimulus and the cell type. Thus, for
all tested conditions targeted ADP-ribosylation to defined chromatin loci either functionally regulated
chromatin structure (as for H2O2) or gene transcription (SOX2 and PPAR￿). How the target specificity
of ADP-ribosylation in the chromatin context is achieved needs further investigation. Zusammenfassung
Protein ADP-Ribosylierung ist eine post-translatare Modifikation bei der ADP-ribose an Zielproteine
angehängt wird. Die verantwortlichen nuklearen Enzyme werden ADP-ribosyl-transferases diphteria
toxin like (ARTDs) genannt, wobei ARTD1 am besten beschrieben ist. Die zellulären Prozesse bei denen
ADP-Ribosylierung involviert ist, reichen von der Erhaltung der Genomintegrität und der DNS Reparatur
bis hin zur Gentranskription. Dennoch ist sehr wenig über die Lokalisation und die molekulare Funktion
von Chromatin-assoziierter ADP-Ribosylierung bekannt. In dieser Arbeit haben wir die mechanistis-
che Rolle von ARTD1 erzeugter poly- ADP-Ribosylierung (PARylierung) unter verschiedenen zellulären
Konditionen untersucht. Im ersten Paradigma untersuchten wir die Rolle der ADP-Ribosylierung von
SOX2 Zielgenen während der frühen Phase der Fibroblasten Reprogrammierung in induzierte pluripotente
Stammzellen (iPSZ). Wir konnten zeigen, dass ARTD1 für die Formierung von iPS Zellkolonien nötig
ist und dass PARylierung von SOX2 wichtig ist, damit Fgf4 effizient transkribiert wird. Die exogenen
Zugabe von FGF4 kompensierte die Inhibierung von PARylierung oder die Ablation von ARTD1. Des
weiteren haben wir ein neues Chromatin Affinität Präzipitations Protokoll (ChAP) entwickelt, womit
ADP-Ribosyliertes Chromatin angereichert werden kann und die Lokalisation der ADP-Ribosylierung
geklärt werden kann. Wir haben dieses Protokoll auf ein oxidatives Stress Paradigma angewandt und
gefunden, dass Wasserstoffperoxid (H2O2) induzierte ADP-Ribosylierung vorzugsweise zu Nukleosom-
dichten heterochromatischen Regionen sowie zu repetitiven Elementen im Genom lokalisiert. Die an
diesen Loci induzierte Chromatin ADP-Ribosylierung korrelierte mit einer höheren Zugänglichkeit des
Chromatins. Zusätzlich war während der in vitro induzierten Adipogenese, die ADP-Ribosylierung eng
mit PPAR￿ bei dessen Zielgenen assoziiert. Zusammengenommen zeigt diese Arbeit, dass die Induktion
und genomische Distribution von Chromatin-assoziierter ADP-Ribosylierung vom Stimulus und Zelltyp
abhängt. Unter allen getesteten Konditionen hat die zielgerichtete ADP- Ribosylierung zu bestimmten
Chromatin Loci entweder die funktionelle Chromatin Struktur (bei H2O2), oder die Gentranskription
(bei SOX2 und PPAR￿) reguliert. Wie die zielgerichtete Spezifität der ADP-Ribosylierung im Kontext
von Chromatin erreicht wird bedarf weiterer Untersuchungen.
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Summary 
Protein ADP-ribosylation is a post-translational modification (PTM) that consists of 
the addition of ADP-ribose moieties to target proteins. In the nucleus, the 
modification is catalyzed by members of the diphtheria toxin-like ADP-ribosyl-
transferases (ARTDs), of which ARTD1 is the nuclear most abundant and best 
studied. ADP-ribosylation has been implicated in a variety of cellular processes, 
ranging from maintenance of genome integrity and DNA repair and gene 
transcription. However, very little is known about the localization and molecular 
function of chromatin-associated ADP-ribosylation.  
In this thesis, we have investigated the mechanistic role of ARTD1-mediated 
chromatin poly-ADP-ribosylation (PARylation) for different cellular conditions. In 
the first paradigm, we investigated the role of ADP-ribosylation for the transcription 
of SOX2 target genes during the early phase of fibroblasts reprogramming to induced 
pluripotent stem cells (iPSC). We could show that ARTD1 and PARylation are 
necessary for iPS colony formation and that PAR formation keeps SRY (sex 
determining region Y)-box 2 (SOX2) associated to the DNA to efficiently transcribe 
SOX2 target genes, including fibroblast growth factor 4 (Fgf4). We found that 
exogenous FGF4 administration functionally rescues ARTD1 ablation or inhibition of 
PARylation. In addition, we have developed a novel chromatin affinity precipitation 
(ChAP) protocol to enrich ADP-ribosylated chromatin for elucidating where ADP-
ribosylation is localized. We have applied this protocol to an oxidative stress 
paradigm and found that ADP-ribosylation induced by hydrogen peroxide (H2O2) 
preferentially localizes to ARTD1 and nucleosome-dense heterochromatic regions, as 
well as to repetitive elements within the genome. Chromatin ADP-ribosylation 
induced at these sites was correlated with a higher accessibility. Moreover during in 
vitro induced adipogenesis, ADP-ribosylation was tightly associated with peroxisome 
proliferator-activated receptor (PPAR!) at PPAR! target genes.  
Together, the thesis reveals that chromatin-associated ADP-ribosylation is a PTM 
whose induction and genomic distribution varies with the stimulus and the cell type. 
Thus, for all tested conditions targeted ADP-ribosylation to defined chromatin loci 
either functionally regulated chromatin structure (as for H2O2) or gene transcription 
(SOX2 and PPAR!). How the target specificity of ADP-ribosylation in the chromatin 
context is achieved needs further investigation.  
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Zusammenfassung 
Protein ADP-Ribosylierung ist eine post-translatare Modifikation bei der ADP-ribose 
an Zielproteine angehängt wird. Die verantwortlichen nuklearen Enzyme werden 
ADP-ribosyl-transferases diphteria toxin like (ARTDs) genannt, wobei ARTD1 am 
besten beschrieben ist. Die zellulären Prozesse bei denen ADP-Ribosylierung 
involviert ist, reichen von der Erhaltung der Genomintegrität und der DNS Reparatur 
bis hin zur Gentranskription. Dennoch ist sehr wenig über die Lokalisation und die 
molekulare Funktion von Chromatin-assoziierter ADP-Ribosylierung bekannt. 
In dieser Arbeit haben wir die mechanistische Rolle von ARTD1 erzeugter poly-
ADP-Ribosylierung (PARylierung) unter verschiedenen zellulären Konditionen 
untersucht. Im ersten Paradigma untersuchten wir die Rolle der ADP-Ribosylierung 
von SOX2 Zielgenen während der frühen Phase der Fibroblasten Reprogrammierung 
in induzierte pluripotente Stammzellen (iPSZ). Wir konnten zeigen, dass ARTD1 für 
die Formierung von iPS Zellkolonien nötig ist und dass PARylierung von SOX2 
wichtig ist, damit Fgf4 effizient transkribiert wird. Die exogenen Zugabe von FGF4 
kompensierte die Inhibierung von PARylierung oder die Ablation von ARTD1. Des 
weiteren haben wir ein neues Chromatin Affinität Präzipitations Protokoll (ChAP) 
entwickelt, womit ADP-Ribosyliertes Chromatin angereichert werden kann und die 
Lokalisation der ADP-Ribosylierung geklärt werden kann. Wir haben dieses Protokoll 
auf ein oxidatives Stress Paradigma angewandt und gefunden, dass 
Wasserstoffperoxid (H2O2) induzierte ADP-Ribosylierung vorzugsweise zu 
Nukleosom-dichten heterochromatischen Regionen sowie zu repetitiven Elementen 
im Genom lokalisiert. Die an diesen Loci induzierte Chromatin ADP-Ribosylierung 
korrelierte mit einer höheren Zugänglichkeit des Chromatins. Zusätzlich war während 
der in vitro induzierten Adipogenese, die ADP-Ribosylierung eng mit PPAR! bei 
dessen Zielgenen assoziiert.  
Zusammengenommen zeigt diese Arbeit, dass die Induktion und genomische 
Distribution von Chromatin-assoziierter ADP-Ribosylierung vom Stimulus und 
Zelltyp abhängt. Unter allen getesteten Konditionen hat die zielgerichtete ADP-
Ribosylierung zu bestimmten Chromatin Loci entweder die funktionelle Chromatin 
Struktur (bei H2O2), oder die Gentranskription (bei SOX2 und PPAR!) reguliert. Wie 
die zielgerichtete Spezifität der ADP-Ribosylierung im Kontext von Chromatin 
erreicht wird bedarf weiterer Untersuchungen.  
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Abbreviations 
aa     Amino acid 
ADPr     Adenosine diphosphate ribose 
ARH     ADP-ribosyl hydrolase  
ART     ADP-ribosyltransferase 
ARTD    ADP-ribosyltransferase diphtheria toxin-like 
ARTC     ADP-ribosyltransferase cholera toxin-like 
ATP    Adenosine triphosphate 
BAT     Brown adipose tissue 
BER     Base excision repair 
bp     Base pair 
BRCT     BRCA1 carboxy-terminal domain 
C/EBP    CCAAT/enhancer binding protein 
ChIP     Chromatin immunoprecipitation 
DAPI     4',6-diamidino-2-phenylindole 
DDR     DNA damage response 
DNA     Deoxyribonucleic acid 
DNMT    DNA methyltransferase 
DSB     Double-strand break 
dsDNA   Double-stranded DNA 
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FGF4     Fibroblast growth factor 4 
HDAC    Histone deacteylase 
H2O2     Hydrogen peroxide 
H3K4me1   Histone H3 lysine 4 mono-methylation 
H3K4me2   Histone H3 lysine 4 di-methylation 
H3K4me3   Histone H3 lysine 4 tri-methylation 
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H3K27Ac   Histone H3 lysine 27 acetylation 
H3K27me3   Histone H3 lysine 27 tri-methylation 
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SSB     Single-strand break 
TNF#     Tumor necrosis factor # 
WAT     White adipose tissue 
XRCC1/4    X-ray repair cross-complementing protein 1/4 
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1 Introduction 
 Chromatin 1.1
The genome is the entire set of genetic information of a certain organism. The human 
haploid genome is divided in 22 autosomal and one sexual chromosome and 
composed of 3.3 billion deoxyribonucleotides (nt) forming the DNA1,2. The genomic 
DNA is enclosed in the nucleus with the exception of a small molecule of 
mitochondrion DNA. The nuclear DNA, proteins and RNAs form a highly dynamic 
macromolecular complex named chromatin. The chromatin main functions are to fit 
the DNA in the nucleus, preserve the DNA integrity from harmful agents and to 
regulate the accessibility to the genomic information (e.g. during transcription)1,2. 
Chromatin is hierarchically organized. On the first level the naked DNA is wrapped 
around the first basic unit, the nucleosomes. Nucleosomes are composed of 8 histone 
proteins, the octameric nucleosome core, and a 147 bp long stretch of DNA wrapped 
1.7 times around the nucleosome core. The nucleosome position is determined by 
several factors, including the DNA sequence, the presence of DNA-binding proteins, 
the action of ATP-dependent nucleosome remodelers, the transcription machinery, 
DNA-replication complex and repair factors3-5. The resulting structure is called the 10 
nm fiber and corresponds to chromatin in open conformation (Fig.1)6. 
 
 
Figure 1: The chromatins hierarchy. Modified from7 . 
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The 10 nm fiber is further folded into the 30 nm fiber by the addition of the linker 
histone H1. The 30 nm fiber is more compacted compare to the 10 nm fiber8. 
Ultimately, during the mitotic metaphase, when the duplicated genome has to be 
equally distributed between the 2 daughter cells, chromatin reaches its highest 
condensation in the chromosomes, structures that ensure the proper segregation of the 
genetic information9. The classical vision of the chromatin hierarchy as been recently 
challenged because, although some experimental evidences have proved the existence 
of the 30 nm fiber in vitro, other studies failed to detect such structure in vivo 10,11.  
1.1.1 Histones 
Histones are a family of basic proteins characterized by a common globular “helix 
turn helix turn helix” motif that facilitates their dimerization and two terminal tails, 
one at the N-terminus and the other at the C-terminus, that undergo extensive post-
translational modification to regulate the nucleosome properties6,12. Histones are 
subdivided into five classes: histone H1, H2A, H2B, H3 and H4. Two H2A-H2B 
dimers and two H3-H4 dimers complexed together compose the octameric 
nucleosome core, whereas histone H1 binds the linker DNA within two adjacent 
nucleosomes and is responsible for nucleosome-nucleosome interaction and local 
chromatin compaction (see 1.1). In addition to the canonical histones, each histone 
class also encompasses a number of non-allelic variants commonly referred to as 
histone variants13. Histone variants diverge from the canonical histones due to 
mutations in their primary sequence that confer them different structural and 
functional properties. While canonical histones are primarily expressed in S-phase 
and deposited on the DNA in a replication-dependent manner, histone variants are 
expressed throughout the cell cycle and their distribution is restricted to defined 
genomic loci, tissues and development stages13.  
1.1.2 Histone post-translational modifications 
Histones, like many other proteins, are post-translational modified when one or more 
amino acids are covalently linked to certain chemical groups. In the case of histones 
the two terminal tails are extensively modified, whereas the globular domain shows a 
lower extent of modification14. Among the many modifications, the most studied and 
relevant are acetylation, methylation, phosphorylation, sumoylation, ubiquitylation 
and ADP-ribosylation15. The enzymes responsible for the deposition of a certain 
modification are called “writers”, the proteins that recognize and bind the 
    Introduction 
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modification are called “readers”, whereas the enzymes that remove the modification 
are called “erasers”16. On one side, these modifications change the chemical and 
physical properties of the nucleosome and on the other side, they represent docking 
platforms for chromatin remodelers and transcription factors, important effector 
proteins that carry out specific biological processes. Since more than one histone post-
translational modifications (PTM) can be deposited on the same nucleosome or on 
adjacent nucleosomes, the existence of a histone code has been postulated17. The 
histone code is a signature of PTMs that mechanistically define the function for a 
specific region of chromatin. For example, high levels of histone H3 lysine 4 mono-
methylation (H3K4me1) and low amount of histone H3 lysine 4 di-methylation 
(H3K4me2) and histone H3 lysine 27 acetylation (H3K27Ac), in combination with 
the presence of lineage specific transcription factors, define active enhancer regions 
whereas, if histone H3 lysine 27 is tri-methylated (H3K27me3), it becomes a common 
signature of posed enhancers18.  
The euchromatin is characterized by the presence of transcription factors, low 
nucleosome density and enriched in histone marks such as histone H3 and H4 
acetylation, histone H3 lysine 4 tri-methylation (H3K4me3) and histone H3 lysine 36 
tri-methylation (H3K36me3)19. Instead, the heterochromatin is a nucleosome dense 
structure with histone marks such as histone H3 lysine 9 tri-methylation (H3K9me3), 
H3K27me3 and histone H4 lysine 20 methylation20. 
In this way PTM of histones and more generally chromatin-associated proteins define 
the chromatin landscape and fine-tune virtually all the processes in the nucleus15.  
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 Protein ADP-ribosylation 1.2
Protein ADP-ribosylation is a PTM generated by a class of enzymes named ADP-
ribosyltransferases (ARTs) that uses the nicotinamide adenine dinucleotide (NAD+) to 
covalently attach adenosine diphosphate ribose (ADPr) to a specific protein-residue 
and release a free molecule of nicotinamide (Fig.2)21.  
 
 
  
Figure 2: Schematic representation of ADP-ribose transfer reaction. 
 
ADPr is a chemical structure that at physiological pH carries 2 negative charges and a 
high-energy pyrophosphate bond22. ARTs specifically modify extracellular, 
cytoplasmic as well as nuclear and chromatin-associated proteins including histones23. 
Several amino acids have been shown to be acceptors of ADPr: arginine, asparagine, 
glutamic acids, aspartic acid, cysteine and more recently lysine 23,24. Since the first 
ADPr can be further extended by the subsequent addition of ADPr units, ADP-
ribosylation can be either classified as mono-ADP-ribosylation (MARylation) or 
poly-ADP-ribosylation (PARylation)25. The half-life of protein ADP-ribosylation can 
be as short as few seconds or within the hour range, depending on the nature of the 
stimulus26,27. This is controlled by the activity of the ADP-ribose hydrolases that 
reverse the formation of ADP-ribosylation by degrading the polymers and removing 
the protein-bound ADPr moiety. Poly-ADP-ribose glycohydrolases (PARG) and 
ADP-ribosylhydrolase 3 (ARH3) were shown to hydrolase PAR whereas ARH1, the 
human macrodomain-containing protein D1 (MDO1), D2 (MDO2), C6orf130 and the 
archeabacteriae Af1521 are able to release the protein-bound ADPr from specific 
amino acids, rendering ADP-ribosylation a reversible modification28-31.  
1.2.1 Mono-ADP-ribosylation 
MARylation was first discovered to be catalyzed by certain bacterial toxins. Cholera, 
diphtheria and pertussis toxins catalyze the MARlation of host proteins such as actin, 
elongation factor 2, Rho and Rac to inhibit their activity and contribute to the 
Protein MonoADP-ribosylated_Protein  
ARTD, 
 NAD+ 
 PolyADP-ribosylated_Protein  
NAM NAM 
ARTD, 
 NAD+ 
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pathological condition observed after bacterial infection32. More recently intracellular 
and extracellular MARlation has been described as regulator of gene transcription, 
inflammation and cell differentiation31,33.  
1.2.2 Poly-ADP-ribosylation 
De novo protein PARylation is initiated with the transfer of an ADPr to a specific 
amino acid to generate a MARylated residue. This protein-bound moiety is then 
extended with a second ADPr through a glycosidic ribose-ribose bond. This 
elongation is repeated to give rise to an oligomer and eventually a polymer of ADPr. 
Polymers can be linear or branched and can reach a length of 400 moieties in vitro34. 
MARylation as well as PARylation change the behavior of the target protein in a 
manner that is dependent on the nature of the protein and on the context. PARylation 
has been described to modulate the activity of its targets in both directions: they can 
either been activated or inhibited35-37. In addition, PAR functions as a scaffold to 
recruit specific PAR-binding proteins, generating a complex protein network whose 
functions are still largely unknown38-40. PARylation has been reported to influence a 
growing number of cellular processes such as DNA repair, transcription, chromatin 
remodeling, RNA maturation and degradation, telomere maintenance, inflammation, 
stress response, cell differentiation and reprograming25.  
1.2.3 ADP-ribosyl transferases (ARTs) 
The enzymes responsible for generating ADP-ribosylation are named ARTs and are 
subdivided into two classes according to the structural similarity of their catalytic 
domain to cholera (ARTCs) or diphtheria (ARTDs) toxin41. The members of the 
ARTC subfamily are mainly anchored to the cytoplasmic membrane acting in the 
extracellular space as mono-ADP-ribosyltransferases41. The ARTD family 
encompasses eighteen proteins (ARTD1-18) in human and seventeen in mouse that 
share a common catalytic domain41. A recent study, aiming at characterizing the 
activity of each member of the ARTD family, reported that ARTD1, 2, 5 and 6 are 
able to generate PAR, ARTD9 and 13 are inactive and all the other members are only 
capable of transferring a single ADPr to the target amino acid42. Nevertheless, 
contradictory reports have been published for some ARTDs. For example, it is not 
clear whether ARTD3 is a mono- or poly-ART42-44. The most abundant and most 
studied member of the ARTD family is ARTD1, formerly named poly-ADP-ribose 
polymerase 1 (PARP1). ARTD1 is an abundant nuclear and chromatin-associated 
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protein responsible for most of the nuclear poly-ADP-ribosylation45,46. Very long 
investigated for its role in DNA repair (see 1.5.3), ARTD1 has emerged more recently 
as a transcription regulator25. ARTD1 is recruited to both euchromatin as well as 
heterochromatin, modulating chromatin function in a context-dependent manner.  
1.2.4 ADP-ribose binders and their application to enrich ADP-ribosylated 
proteins 
ADPr binders are protein domains that bind to ADP-ribosylated proteins and act as 
“readers” of such modification. Four main classes of ADPr binders have been 
identified so far, including the macrodomain, the PAR-binding motif (PBM), the 
PAR-binding zinc-finger domain (PBZ) and the WWE domain (Fig.3)25,47.  
 
 
Figure 3: Representation of ADP-ribose binders specificity25 
 
The madrodomains are evolutionary conserved protein modules sharing a high degree 
of structural homology25. Differences in the macrodomain structures account for their 
selective binding to MAR, PAR or both of them48. Some macrodomains are also able 
to hydrolase ADP-ribosylation and are therefore ADPr “erasers” (see above 1.1.2). 
The WWE domains are positive charged protein domains composed of a half $-barrel 
juxtaposed to a #-helix named after the 3 conserved amino acids in the primary 
sequence49. WWE domains recognize the smallest PAR structural unit, the iso-ADPr, 
and do not bind to MARylated proteins25,49. They are found in E3-ubiquitine ligases 
or ARTDs as a single domain or in tandem41,50. Both the PBM and PBZ recognize 
PAR but not MAR25. 
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The high affinity of such domains for PAR or MAR makes them suitable tools for 
studying ADP-ribosylated proteins51. Indeed, in order to study protein ADP-
ribosylation in the cellular context, it is necessary to isolate proteins that are modified 
from the ones that are not. Until recently, an anti-PAR antibody developed in the 
early 80’s, named 10H, has been the most commonly used tool to investigate protein 
AD-ribosylation64. 10H is a mouse monoclonal antibody with high affinity for linear 
and long PAR (>20mer), moderate affinity for shorter polymers (10-30mer) and 
unable to recognize shorter oligomers of ADP-ribose or MARylation52,53. Although 
the 10H antibody is an important tool, the requirement of long polymers for its 
binding, limits its usage. Other anti-PAR antibodies, that recognize shorter polymers, 
have been recently developed and are now commercially available54. However, the 
exact epitope they recognize and whether extensively branched polymers are 
recognized as well is not yet clear55,56. To overcome these limitations recent studies 
have replaced the anti-PAR antibodies with ADP-ribose binders of different 
origins57,58. The macrodomains, for example, represent powerful baits that can be 
used to address whether a protein is PARylated or MARylated. Indeed, the Af1521 
macrodomain from Archeaoglobus fulgidus has been recently used as bait to enrich 
for ADP-ribosylated proteins in large-scale mass spectrometry screenings aimed at 
defining the cellular ADP-ribosylome57,58. Other ADPr binders have been 
characterized for their capacity to bind ADP-ribosylated proteins. In particular the 
histone H2A1.1’s macrodomain has high affinity for PAR whereas the ARTD9 
macrodomains 1 and 2 recognize MARylated ARTD1059,60. The WWE domains bind 
to iso-ADP-ribose, the smallest PAR structure, and are therefore able to pull-down 
short oligomers as well as long PAR but do not recognize MARylated proteins49. 
Thus, the WWE domains can be exploited to discriminate PARylated proteins 
irrespectively of the length or structure of the modification. Another strategy to isolate 
ADP-ribosylated proteins takes advantage of resins coupled to boronic acid, which 
covalently binds to the cis-diol groups of the riboses in the ADPr moiety56. Although 
this technique has been used to identify ADP-ribosylated proteins in cell and tissue 
extracts, the boronate group does not only bind to ADPr, but also to other organic cis-
diol groups, thus representing a potential source of bias61,62. An alternative approach 
relies on the permeabilization of cells and their incubation with NAD+ derivatives 
such as biotinylated NAD+ or 1,N6etheno NAD+. Once in the cells, these compounds 
are used, although with lower efficiency, by ARTDs to modify target proteins55,63,64. 
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The modified proteins can then be separated either by resin affinity purification or 
with specific antibodies. The drawback of these protocols is that the cell 
permeabilization step may induce biological artifacts and that the lower efficiency of 
incorporation may lead to an underestimation of the proteins that are ADP-
ribosylated.  
 
1.2.5 ADP-ribosylation in the chromatin context 
Very little is known about chromatin-associated ADP-ribosylation in vivo and its 
interplay with other histone modifications or the chromatin context where it is 
formed. Recent studies on Drosophila have revealed that ARTD1 is recruited to the 
linker DNA between 2 nucleosomes of which one contains the canonical histone 
H2A, whereas the other incorporates the histone variants H2Av, the homologous of 
the human H2Ax and H2Az65. In this context, phosphorylation of H2Av serine 137 on 
one nucleosome and acetylation of H2A lysine 5 on the other promote PAR formation 
to induce nucleosome eviction and efficient gene transcription in response to heat 
shock65. Along the same line, ARTD1-mediated ADP-ribosylation has been reported 
to promote gene transcription in lipopolysaccharide (LPS)-stimulated murine 
macrophages by histone PARylation and subsequent nucleosome eviction from the 
promoters of NF-"B target gene64,66. However, other study have shown that, upon cell 
stimulation with LPS, ARTD1 recruits p65 and the histone acetyl-transferase p300 to 
reorganize the local chromatin and promote the transcription of NF-"B target genes in 
an ADP-ribosylation independent manner67. In addition, the human ARTD1 has been 
described to replace histone H1 at active promoters68. In line with these evidences, 
ARTD1 PARylates KDM5B to inhibit H3K4me3 demethylation therefore placing 
ADP-ribosylation in an open chromatin context and functionally linking it to gene 
transcription36. Conversely, after nuclear micro irradiation, ARTD1 activation 
influences the genomic localization of the human histone variant macroH2A1.1, an 
ADPr binder, to enhance local genomic compaction59. Furthermore, nuclear ADP-
ribosylation has been implicated in the maintenance of rDNA repression after DNA 
replication, placing ADP-ribosylation in a completely different heterochromatic 
context37,55. In line with that, heterochromatin-associated ARTD1 and ADP-
ribosylation has been reported to modulated UHRF1 and DMNT1 activity and to 
promote the re-establishment of rDNA silencing37,69,70. Collectively all these 
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evidences suggest that chromatin-associated ADP-ribosylation is restricted to defined 
genomic regions and that its functional outcomes are influenced by the chromatin 
context where it is formed. 
 Cell fate determination 1.3
Every cell in a complex organism originates from a single totipotent cell through a 
hierarchical process encompassing several steps of cell proliferation, fate 
commitment, cell specification and chromatin rearrangements that eventually lead to 
fully differentiated somatic cells71. These processes are subject to tight regulation and 
play a fundamental role during tissue development and regeneration and maintenance 
of body homeostasis. However, somatic cells can also be reprogrammed in order to 
re-acquire pluripotent or totipotent features. This is the case during gametogenesis, in 
vitro reprogramming or tumorigenesis and metastasis72,73. Interestingly, ADP-
ribosylation has been reported to act in all the above-mentioned processes. For 
instance, depletion of the only Drosophila ARTD or mouse co-depletion of ARTD1 
and ARTD2, the two prominent nuclear PAR-generating enzymes in mammals, have 
lethal effects at the larvae or embryonic stage respectively, suggesting that ADP-
ribosylation is essential for proper development of multicellular organisms74,75. In 
addition, ARTD1 has been reported to PARylate SRY (sex determining region Y)-
box 2 (SOX2), a major pluripotent transcription factor, in embryonic stem (ES) cells 
and promote cell differentiation76. Conversely, upon embryonic reprogramming of 
mouse germ line, ADP-ribosylation enhances the acquisition of genomic pluripotent 
features by erasing DNA methylation77.  
1.3.1 Induced pluripotent stem cells 
Induced pluripotent stem cells (iPSC) are pluripotent stem cells that originate from 
somatic cells through an engineering process72. In 2006, the Yamanaka laboratory 
discovered that retroviral transduction of fibroblasts with the transcription factors 
octamer-binding transcription factor 4 (OCT4), SOX2, Kruppel-like factor 4 (KLF4) 
and V-Myc Avian Myelocytomatosis Viral Oncogene Homolog (c-MYC) (named the 
Yamanaka factors) was sufficient to reprogram somatic cells to pluripotent stem cells 
capable of differentiating to any of the three germ layers72. Despite the promising 
application in regenerative medicine, a better understanding of the molecular 
mechanisms that drive reprogramming is necessary, especially considering that iPSC 
are generated by stably overexpressing 4 oncogenes that may potentially give rise to 
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malignant cells. To overcome this risk, new protocols have been developed. 
Retroviral transduction of the Yamanaka factors has been replaced with transient 
transfection of these factors and their number was reduced to three or two, in 
combination with small molecule HDAC inhibitors78. The two factors that seem to be 
essential at the onset of reprogramming are OCT4 and SOX2. They act singularly or 
together to sustain self-renewal and pluripotency78. Interestingly, SOX2 not only 
regulates reprograming, but its fine-tuned expression is one of the determinants in 
keeping a stem cell pluripotent or pushing it into differentiatiation79. In particular, 
SOX2 has been implicated in neuronal differentiation and neuronal progenitor 
maintenance80. Mechanistically, SOX2 binds the promoter or regulatory regions of 
target genes and promotes their transcription as single transcription factor or in 
complex with OCT4 and NANOG80. This is also the case for the fibroblast growth 
factor 4 (FGF4), whose expression in the epiblast as well as in vitro cultured ES cells 
is driven by SOX281. The expression of FGF4, in turn, induces the paracrine secretion 
of FGF4 sustaining trophoblast stem cell renewal and multipotency. SOX2 is thus a 
master regulator of reprogramming via fine-tuning complex pathways that are not yet 
completely understood. Full understanding of the reprograming process is needed to 
generate new powerful tools in regenerative medicine and to avoid the risk of cancer 
development in patients.  
1.3.2 Adipogenesis 
The adipose tissue is a complex network of cells, primarily adipocytes, with several 
functions, such as maintenance of body lipid homeostasis, body energy storage and 
regulation as well as adipokines and hormones production109. Its mis-regulation is 
linked to metabolic disorders such as diabetes, atherosclerosis, obesity and cancer82,83. 
Adipocytes are classified into white adipocytes and brown adipocytes84. Although 
these two classes of cells have different functions, they are tightly related. White 
adipocytes can trans-differentiate into brown ones and vice versa, rendering 
adipogenesis, the generation of adipocytes, a “two-way” process. White adipocytes, 
together with precursor cells, endothelial cells, immune cells and fibroblasts 
constitute the white adipose tissue (WAT) whose main functions are to insulate the 
body, generate a mechanical barrier to protect the body, store energy and to produce 
adipokines84,85. The brown adipose tissue (BAT) is responsible for lipid oxidation and 
heat generation, thus contributing to body temperature homeostasis78. Cell 
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differentiation into adipocytes is a complex process that can be recapitulated using a 
model cell line (3T3L1) in vitro 86. During the early phase of differentiation, cells 
express the CCAAT/enhancer binding protein (C/EBP) -$ and -%, two key 
transcription factors that drive differentiation by promoting the transcription of 
C/EBP# and of the peroxisome proliferator-activated receptor ! (PPAR!) in the late 
phase87. The latter is a nuclear receptor that, in response to not yet fully characterized 
ligands, interacts with the retinoid X receptor (RXR) and is then recruited to PPAR! 
target genes promoting their transcription87. PPAR! target genes are characterized by 
the presence of cis-regulatory sequences named PPAR! response elements (PPRE), 
where PPAR! binds, bringing along the histone acetyltransferases p300-CBP88,89. 
Interestingly, ARTD1-mediated PARylation has been shown to increase during 
differentiation and ARTD1 ablation or inhibition of ADP-ribosylation both hampers 
adipogenesis in vivo and in vitro90,91. Mechanistically, ARTD1 is activated by 
topoisomerase-II (TOPOII) at PPAR! target genes where PAR formation enhances 
PPAR! ligand binding, which subsequently induces co-factor exchange (i.e. p300-
CBP recruitment) and chromatin remodeling to stimulate gene transcription92. 
 Oxidative stress and H2O2signaling 1.4
1.4.1 Oxidative stress 
Oxidative stress is an imbalanced condition between the amount of free radicals in the 
cell and the cell antioxidant capacity93. Reactive oxygen species (ROS) are of 
environmental as well as of endogenous origin. For instance, during mitochondrial 
respiration, superoxide anions (O2-) are generated and need to be converted by the 
superoxide dismutase (SOD) to the less harmful hydrogen peroxide (H2O2) that is 
eventually transformed by catalases to H2O94. H2O2 has been implicated in cell 
signaling and tissue regeneration95-97. For example, in response to tissue injury, 
epithelial cells produce H2O2 that acts as chemo-attractor for neutrophils and 
leukocytes to prevent possible infection98. In addition, H2O2 contributes to 
angiogenesis and epithelial cell migration by activating signal cascades such as 
ERK1/2 phosphorylation and NF-"B nuclear translocation to promote the 
transcription of pro-inflammatory genes and genes involved in wound healing, such 
as VEGF, IL8 and MUC199,100.   
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1.4.2 H2O2 signaling 
The intracellular mechanisms that sense H2O2 and initiate the signaling cascades have 
not been fully identified, but it seems that metallo-enzymes as well as cysteine 
oxidation play a great role101,102. In particular, the cysteine thiolate (-S-) is prone to be 
oxidized by H2O2 to sulfenic acid (-S-OH) and further to sulfinic (S-O2H) and 
sulfonic (S-O3H) acid and to form cysteine-cysteine bonds101. Each intermediate can 
be rapidly reversed when normo-conditions are re-established. H2O2 has not only 
been correlated with protein oxidation, but also with lipid oxidation as well as single 
strand (ssDNA) and double strand DNA (dsDNA) damage, leading to activation of 
DNA repair pathways, increased DNA mutations and cell death103-105. Although the 
exact mechanism by which H2O2 induces DNA damage is not completely understood, 
it seems that chromatin-associated iron mediates the formation of damages that can 
target either the nucleobases of the DNA, that may lead to DNA mutations if not 
properly repaired, or the sugar bonds, leading to the generation of ssDNA breaks that, 
if not efficiently repaired before DNA replication, may cause stalling of the DNA 
replication fork and eventually generate dsDNA breaks106-108 
1.4.3 PAR in Base Excision Repair (BER) pathway 
Oxidized DNA bases, such as 8-oxoguanines, are recognized and excised by the 
OGG1 glycosylase109. This reaction leaves the DNA with an abasic site, also known 
as AP site. The BER pathway is responsible for repairing DNA base lesions or 
ssDNA breaks110. The AP site is further processed by an AP endonuclease to generate 
a single strand nick. This intermediate is then bound by polynucleotide kinase-
phosphatase (PNKP) to generate the proper 3’ hydroxyl and 5’ phosphate ends that 
are required for pol $ and & to fill the gap replacing the single nucleotide (short-patch 
BER) or for pol ' and pol ( to synthetize a larger stretch of DNA displacing the 
damaged strand (long patch BER). In this latter case, the displaced ssDNA must be 
removed by the FEN1 endonuclease. Eventually, both short and long patch BER 
pathways end with DNA ligase I or III that seals the nick109. Although it is well 
established that intracellular oxidative stress (e.g. treatment with H2O2) induces 
nuclear PAR formation, its role in BER is still under debate111. Some reports have 
shown that DNA lesions activate ARTD1 and that its activity is involved in recruiting 
XRCC1 to the damaged site112,113. In contrast, other reports excluded that ARTD1 and 
PAR have any implication in the first phases of BER, suggesting that ARTD1 may 
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only be activated to protect the damaged sites from nuclease attacks when the cellular 
repair capacity is exceeded114,115. Interestingly, in response to DNA damage or H2O2, 
ARTD1 is phosphorylated by ERK1/2 and JNK1, which leads to enhanced and 
sustained PAR formation, indicating that PAR formation is not a mere consequence of 
DNA damage detection by ARTD1 but rather the result of several regulated factors 
connecting PAR formation to cell signaling116,117. 
 
 ARTD1 and ADP-ribosylation in inflammation 1.5
Due to the role of ARTD1 and ARTD2 in DNA repair (see 1.4.3 and 118) inhibitors of 
ADP-ribosylation have been primarily used to enhance the anti-cancer effects of some 
DNA damage-inducing chemotherapies or radiation therapy in BRCA1/2 mutant 
breast tumor and in other malignant cancers119,120. However, inhibitors of ADP-
ribosylation have been also considered for the treatment of other acute and chronic 
disorders such as cardiac, neuronal, metabolic and inflammatory diseases120. In line 
with that, inhibitors of ADP-ribosylation have shown protective effects in several 
inflammatory disorders, stressing the medical relevance of ADP-ribosylation in 
inflammation121. For example, murine macrophages treated with the inhibitor of 
ADP-ribosylation PJ34 upon exposure to LPS, showed reduced pro-inflammatory 
cytokines production compared to non-inhibited cells64. Furthermore, mice lacking 
ARTD1 are resistant to LPS induced endotoxic shock and release less TNF-#, IFN-! 
and nitric oxide into the blood stream when compared to wild-type mice 122. ARTD1 
has also been implicated in T-lymphocyte differentiation and inhibitors of ADP-
ribosylation have been reported to protect from excessive inflammatory activation, 
indicating that ADP-ribosylation may enhance inflammation and induce cell necrosis 
due to over-production of cytokines121. In addition, ARTD1-/- cells fail to activate a 
NF-"B dependent reporter gene and only the genetic complementation of cells with 
ARTD1 allowed successful gene expression122,123. These data suggest that ARTD1 
functions in transcription as co-factor of NF-"B, even though it is still under debate 
whether ADP-ribosylation is directly involved in NF-"B target gene 
transcription64,124,125. Indeed, most of the inhibitors of ADP-ribosylation used to 
address the implication of ARTD1 enzymatic activity on NF-"B target gene 
transcription belong to the first or second generation of inhibitors, which may have 
off-target effects25,126. 
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2 Aim of the thesis 
ADP-ribosylation is a protein PTM linked to a broad variety of physiological and 
pathophysiological processes such as tissue development, inflammation and cancer 
onset or progression. Nuclear ADP-ribosylation regulates the intracellular energy 
metabolism, stress response and cell death by locally rearranging chromatin and 
influencing DNA repair and gene transcription. However, due to the lack of suitable 
methodologies, only little is known about the molecular mechanisms that induce 
chromatin-associated ADP-ribosylation and its functional implications.  
Our hypothesis was thus ARTD1 is locally activated on the chromatin to mediate the 
ADP-ribosylation of chromatin-associated proteins and support gene transcription. 
Aim of this thesis was to investigate the functional contribution of ARTD1 and 
chromatin ADP-ribosylation on gene transcription. We approached the biological 
question by: 
a) Addressing how ARTD1-mediated ADP-ribosylation sustains the early phase 
of fibroblasts reprogramming to iPSCs. 
b) Using H2O2-induced PAR formation to develop a novel method that allows the 
detection of chromatin-associated ADP-ribosylated proteins and applying it to 
investigate PAR formation during adipogenesis. 
c) Investigating how ARTD1-mediated ADP-ribosylation influences the 
transcription of NF-"B target genes. 
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3 Results 
 3.1  Published results 
Artd1/Parp1 regulates reprogramming by transcriptional regulation of Fgf4 via 
Sox2 ADP-ribosylation. 
Authors:  Weber FA, Bartolomei G (first co-authorship), Hottiger MO,Cinelli P. 
Journal:  Stem Cells, 2013 
Contribution:  Planning, performing, evaluating experiments for: Fig.1C-F, Fig.2, 
Fig.3B and Supplementary Fig.3. writing and editing manuscript.  
 
 3.2 Submitted manuscript 
A new highly specific ChAP method for the genome-wide localization of 
chromatin ADP-ribosylation. 
Authors: Bartolomei G, Hottiger MO.  
Journal:  Submitted 
Contribution:  Planning, performing and evaluating all the experiments; figures 
preparation; writing and editing manuscript. 
 
 3.3 Unpublished results 
 3.3.1 H2O2-induced ADP-ribosylation does not change chromatin composition 
and is associated with constitutive heterochromatin  
 3.3.2 H2O2-induced ADP-ribosylation or inhibition of ADP-ribosylation do not 
influence NF-!B-dependent gene expression 
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 Published results3.1
EMBRYONIC STEM CELLS/INDUCED PLURIPOTENT STEM CELLS
Artd1/Parp1 Regulates Reprogramming by Transcriptional
Regulation of Fgf4 Via Sox2 ADP-Ribosylation
FABIENNE A. WEBER,a,b GIODY BARTOLOMEI,b,c MICHAEL O. HOTTIGER,b,c,d PAOLO CINELLIa,b,d,e
aInstitute of Laboratory Animal Science, bLife Science Zurich Graduate School; cInstitute of Veterinary
Biochemistry and Molecular Biology, University of Zurich, Zurich, Switzerland, and dCenter for Applied
Biotechnology and Molecular Medicine, University of Zurich, Zurich, Switzerland; eDivision of Trauma Surgery,
Center for Clinical Research, University Hospital Zurich, Zurich, Switzerland
Key Words. Cell biology ? Induced pluripotent stem cells ? Artd1/Parp1 ? Pluripotent stem cells ? Reprogramming ? Fgf4
ABSTRACT
The recently established reprogramming of somatic cells
into induced pluripotent stem cells (iPSCs) by Takahashi
and Yamanaka represents a valuable tool for future thera-
peutic applications. To date, the mechanisms underlying this
process are still largely unknown. In particular, the mecha-
nisms how the Yamanaka factors (Oct4, Sox2, Klf4, and c-
Myc) directly drive reprogramming and which additional
components are involved are still not yet understood. In this
study, we aimed at analyzing the role of ADP-
ribosyltransferase diphtheria toxin-like one (Artd1; formerly
called poly(ADP-ribose) polymerase 1 [Parp1]) during
reprogramming. We found that poly(ADP-ribosylation)
(PARylation) of the reprogramming factor Sox2 by Artd1
plays an important role during the first days upon transduc-
tion with the reprogramming factors. A process that hap-
pens before Artd1 in conjunction with 10–11 translocation-2
(Tet2) mediates the histone modifications necessary for the
establishment of an activated chromatin state at pluripo-
tency loci (e.g., Nanog and Essrb) [Nature 2012;488:652–
655]. Wild-type (WT) fibroblasts treated with an Artd1
inhibitor as well as fibroblasts deficient for Artd1 (Artd12/
2) show strongly decreased reprogramming capacity. Our
data indicate that Artd1-mediated PARylation of Sox2
favors its binding to the fibroblast growth factor 4 (Fgf4)
enhancer, thereby activating Fgf4 expression. The impor-
tance of Fgf4 during the first 4 days upon initiation of
reprogramming was also highlighted by the observation that
exogenous addition of Fgf4 was sufficient to restore the
reprogramming capacity of Artd12/2 fibroblast to WT lev-
els. In conclusion, our data clearly show that the interaction
between Artd1 and Sox2 is crucial for the first steps of the
reprogramming process and that early expression of Fgf4
(day 2 to day 4) is an essential component for the successful
generation of iPSCs. STEM CELLS 2013;31:2364–2373
Disclosure of potential conflicts of interest is found at the end of this article.
INTRODUCTION
The recent discovery of Takahashi and Yamanaka that it is
possible to establish pluripotent stem cells, so called induced
pluripotent stem cells (iPSCs), by reprogramming differenti-
ated somatic cells [1] has opened new perspectives in the
field of regenerative medicine. Therefore, many groups have
worked on the refinement of reprogramming in order to
optimize this technology for the use of iPSCs in clinical
applications (reviewed in [2]). Nevertheless, the molecular
mechanisms underlying the process of reprogramming are still
largely unknown. An increased knowledge on how this pro-
cess is driven and on the underlying mechanisms would lead
to improved, more efficient reprogramming techniques.
Originally, reprogramming of mouse and human fibro-
blasts to iPSCs was performed by the retroviral-mediated
introduction of the four transcription factors, Oct 4, Sox2,
Klf4, and c-Myc (the so called Yamanaka factors [1]). How
these factors directly drive the process of reprogramming and
which additional components are involved still needs to be
carefully analyzed. One of the Yamanaka factors, the tran-
scription factor Sox2 (sex determining region Y-box 2), is a
main player in maintaining pluripotency in embryonic stem
cells (ESCs) [3]. Therefore, the regulation of Sox2 is most
likely critical for the generation of iPSCs. One enzyme that
has been demonstrated to post-translationally regulate Sox2 is
the ADP-ribosyltransferase diphtheria toxin-like 1 (Artd1, for-
merly called Poly(ADP-ribose) polymerase 1/Parp1). Artd1 is
a chromatin associated factor that catalyzes the covalent
attachment of poly(ADP-ribose) (PAR) to itself and to other
nuclear acceptor proteins [4,5]. ADP-ribosylation plays an
important role in numerous biological processes, such as
maintenance of genomic stability, cell differentiation, cell
death, replication, and transcriptional regulation [6,7]. Differ-
ent roles of Artd1 in the regulation and maintenance of pluri-
potency have also been previously described: deletion of
Artd1 in ESCs globally affects gene expression patterns and
Authors contributions: F.A.W: performed the experiments and wrote the manuscript; G.B.: performed the experiments and edited the
manuscript; M.O.H.: supervised the project and edited the manuscript; P.C.: designed the experiments, supervised the project, and wrote
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Artd1 knockout ESCs differentiate into trophoblast derivatives
[8,9]. Furthermore, it was previously shown that Artd1-
dependent PARylation of Sox2 induces its eviction from the
Fgf4 (fibroblast growth factor 4) enhancer and thereby indu-
ces Fgf4 transcriptional activation [10]. In contrast, recently
Lai et al. reported that in ESCs, Artd1 PARylates itself and
thereby enhances its interaction with Sox2, which in turn pre-
vents Sox2 from binding to Oct4/Sox2 enhancers [11]. Previ-
ous work indicates an important role of Artd1 during
reprogramming. Artd1 knockout (Artd12/2) fibroblasts
exhibit impaired reprogramming capacity [11], but the mecha-
nisms underlying this observation were not analyzed. In a
recent work, Doege et al. describe a role of Artd1 in conjunc-
tion with 10–11 translocation-2 (Tet2) in mediating the his-
tone modifications necessary for the establishment of an
activated chromatin state at pluripotency loci [12].
In this study, we aimed at analyzing the role of Artd1
during reprogramming, paying special attention to its role in
the first days upon transduction (days 0–4) of the cells with
the Yamanaka factors. We found that PARylation of Sox2 by
Artd1 between day 0 and day 4 plays an important role in the
generation of iPSCs. Inhibition of the enzymatic activity of
Artd1 during this time period in wild-type (WT) fibroblasts
resulted in a strongly decreased reprogramming efficiency
after retroviral-mediated transduction of the Yamanaka fac-
tors. The same could be observed when using fibroblasts defi-
cient for Artd1 (Artd12/2). Our data further show that
Artd1-mediated PARylation of Sox2 is involved in the regula-
tion of Fgf4 expression. The importance of Fgf4 during the
first steps of reprogramming is also corroborated by our find-
ing that addition of exogenous Fgf4 can rescue the reprog-
ramming deficiency of the Artd12/2 cells.
In conclusion, our data clearly indicate a new role of
Artd1 in regulating Fgf4 activity via Sox2 ADP-ribosylation
during reprogramming and suggest a dual function of Artd1
during this process. Artd1 is essential for starting the Fgf4-
mediated reprogramming process and later establishes the
post-translation modification necessary for the activation of
pluripotency genes [12].
MATERIALS AND METHODS
Reprogramming
Mouse embryonic fibroblasts (MEF) were isolated from 14.5-day-
pregnant C57BL/6 mice and cultured in Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with 10% fetal bovine
serum (PAA) and 1% L-glutamin/penicillin/streptomycin (10,000
U/ml penicillin G sodium; 10,000 mg/ml streptomycin sulfate;
29.2 mg/ml L-glutamine; 10 mM sodium citrate in 0.14% NaCl,
Gibco, Invitrogen, Basel, Switzerland, www.invitrogen.com). The
reprogramming of the MEFs was performed according to Yama-
naka’s protocol [13] using the pMXs retroviral vectors producing
murine Oct4, Sox2, Klf4, and c-Myc (Addgene, cat. nos. 13366,
13367, 13370, and 13375). Two days after infection, MEFs were
cultured in DMEM containing 15% fetal bovine serum, 1% L-glu-
tamin/penicillin/streptomycin, 13 MEM nonessential amino acids
(Gibco, Invitrogen, Basel, Switzerland, www.invitrogen.com),
and 50 mM ß-mercaptoethanol (Gibco, Invitrogen, Basel, Swit-
zerland, www.invitrogen.com) supplemented with 1,000 U/ml
ESGRO murine Leukemia inhibitory factor (Millipore, Chemikon,
Zug, Switzerland, www.millipore.com). FGF4 (Sigma, Buchs,
Switzerland, www.sigmaaldrich.com/switzerland-schweiz.html)
was added during the reprogramming process at 10 ng/ml unless
stated otherwise, ABT-888 (Enzo Life Sciences, New York,
www.enzolifesciences.com) at 10 mM and SU5402 (Millipore,
Calbiochem, Zug, Switzerland, www.millipore.com) at 2 mM.
Immunofluorescence Staining iPSCs
For immunofluorescence staining, iPSCs derived from WT,
Artd12/2 fibroblasts, and Artd12/2 fibroblasts reprogrammed
in the presence of Fgf4 (Artd12/2*) were grown on mitomycin
C-treated MEFs and fixed in 4% paraformaldehyde. Then, iPSCs
were incubated with primary antibodies against Oct4 (rabbit anti-
Oct4, Santa Cruz Biotechnology, Santa Cruz, CA,
www.scbt.com) and SSEA-1 (mouse anti-SSEA-1, Millipore).
Secondary fluorescence-labeled antibodies were used for detection
(goat anti-rabbit Alexa Fluor 594 and goat anti-mouse Alexa
Fluor 488, Molecular Probes, Invitrogen, Basel, Switzerland,
www.invitrogen.com). Nuclei of the cells were counterstained
with 4?,6-diamidino-2-phenylindole (DAPI) (Roche, Basel, Swit-
zerland, www.roche.ch).
Real-Time PCR
Total RNA was isolated using the RNeasy Mini Kit (QIAGEN,
Venlo, Netherlands, www.qiagen.com) and 1 mg of total RNA
was reverse transcribed with Oligo-dT primers (Invitrogen) and
Superscript III (Invitrogen). Real-time PCR was performed in
triplicates in a Rotor-Gene Q RG-6000 (QIAGEN) with Rotor-
Gene SYBR green (QIAGEN) and analyzed with the Delta Ct-
method. GAPDH was used for normalization. Error bars represent
the SD of the mean of triplicate reactions. Primers are listed in
Supporting Information Table S1.
In Vitro Differentiation
For monoculture neural and smooth muscle differentiation, iPSCs
(WT, Artd12/2 and Artd12/2 cells reprogrammed in the pres-
ence of Fgf4 [Artd12/2*]) were plated onto gelatinized 35 mm
dishes. The iPSCs were cultivated for 10 days with neural differ-
entiation medium (DMEM/F-12 [Gibco, Invitrogen, Basel, Swit-
zerland, www.invitrogen.com], N2 [1:100, Gibco, Invitrogen,
Basel, Switzerland, www.invitrogen.com], B27 [1:50, Gibco,
Invitrogen, Basel, Switzerland, www.invitrogen.com], and 1% L-
glutamin/penicillin/streptomycin) or smooth muscle differentiation
medium (DMEM and 10% fetal bovine serum). At day 10, cells
were fixed in 4% paraformaldehyde and stained for bIII-tubulin
(Sigma) and smooth muscle actin (Sigma), respectively.
Western Blotting
Cells were collected in radioimmunoprecipitation RIPA buffer (50
mM Tris-HCl pH 8; 400 mM NaCl; 0.5% Nonidet P40; 1% Na-
Deoxycholate; 0.1% SDS; Protease Inhibitor Cocktail Tablet,
EDTA-free Roche, IN). Proteins were identified by SDS-PAGE
(10% acrylamide) and Western blotting using the following antibod-
ies: a-PAR ALX-210–890 (Enzo Life Sciences, New York,
www.enzolifesciences.com), a-PARP-1/2 (H250) sc-7150, a-Sox2
15830 (Abcam, Cambridge, United Kingdom, www.abcam.com), a-
Pcna (PC10) sc-56, a-tubulin T6199 (Sigma), IRDye 800CW anti-
Rabbit, and IRDye 680RD anti-Mouse (LI-COR, Lincoln, Nebraska,
www.licor.com). Images were acquired with an Odyssey Imaging Sys-
tem (LI-COR).
In Vitro Sox2 ADP-Ribosylation
HEK293 cells were seeded at a density of 2.7 3 106/150 mm
dish and after overnight incubation transfected with pBluescript
II and pCAG-HA-Sox2-IP (cat. no. 13459) vectors, respectively
(using CaCl2 transfection). After 72 hours, cells were harvested
and resuspended in NE buffer (50 mM Tris-HCl [pH 7.5], 0.15
M KCl, 5 mM MgCl2, 0.2 mM EDTA, 20% [vol/vol] Glycerol).
After sonication at 4?C for 2 3 30-second, the cells were incu-
bated with DNase (Fermentas, Thermo Fisher Scientific Waltham,
Massachusetts, http://www.thermoscientificbio.com) for 30
minutes at 4?C. After DNA digestion, the cells were sonicated
for 30 seconds and then centrifuged at 6,000 rpm for 10 minutes.
The cleared lysate was subjected to immunoprecipitation over-
night at 4?C using immobilized antibody against HA (ANTI-HA
affinity gel, Sigma). Precipitates were washed three times with
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NE buffer and after centrifugation; the HA-Sox2 coupled beads
were resuspended in reaction buffer (50 mM Tris-HCl pH8, 4
mM MgCl2, 0.25 mM dithiothreitol, 5 mM NaCl, 200 nM EcoRI
linker). Recombinant human ARTD1 (10 pmol) and 32P-NAD1
(4 nmol) were added and the reactions were incubated for 15
minutes at 30?C. Empty pBlueScript II vector was used as a neg-
ative control and 0.1 mg of histone H1 (10223549001; Roche) as
a positive control. Proteins were resolved by SDS-PAGE (10%
acrylamide), exposed to x-ray film (Tx-RP) and analyzed
(Typhoon imager, GE Healthcare Life Sciences, Switzerland,
http://www.gelifesciences.com).
High Stringency Immunoprecipitation
At day 4, cells were collected in cold phosphate buffered saline
and lysed in hypotonic buffer (5 mM Hepes pH 7.5; 85 mM KCl;
0.5% Nonidet P40; protease inhibitor Roche), and nuclei were
spun down for 10 minutes at 8,000 rpm. Nuclei were then sus-
pended in High Stringency Buffer (50 mM Tris-HCl pH 7.5; 0.4
M NaCl; 1% Nonidet P40; 0.4% Na-Dedoxycholate) followed by
sonication and DNA digestion with DNaseI (Roche). Extracts
were cleared by 10 minutes centrifugation at 14,000 rpm. Cleared
nuclear extracts were diluted 1:2.7 in 50 mM Tris-HCl pH 7.5
and immunoprecipitations were carried out for 2 hours using 10H
antibody or IgG as a negative control. Beads were then washed
three times in the same buffer and lastly boiled in SDS loading
buffer.
Immunofluorescence Staining During Reprogramming
WT and Artd12/2 fibroblasts were seeded on glass coverslips
and reprogramming was induced as previously described. At the
indicated time, cells were fixed in acetic acid/methanol (1:3) for
5 minutes on ice, blocked for 30 minutes in PBSMT (phosphate
buffered saline containing 5% milk and 0.05% Tween-20), incu-
bated with a-Sox2 (15830, Abcam, 1:200) and a-PAR (10H,
Enzo Life Sciences, New York, www.enzolifesciences.com)
(1:250) dissolved in PBSMT for 1 hour at room temperature,
washed with phosphate buffered saline, incubated with secondary
Alexa Fluor 488 a-rabbit (Invitrogen) and Cy3-IgG fraction
monoclonal mouse anti-FITC antibodies, and embedded on
microscopy slides with DAPI containing mounting medium VEC-
TASHIELD. Images were acquired with a Leica SP5 microscope
at the Centre for Microscopy and Image Analysis of the Univer-
sity of Z?urich.
Sox2 Coimmunoprecipitation
WT and Artd12/2 fibroblasts were reprogrammed as previously
described. At the indicated time, cells were harvested and lysed
in hypotonic buffer (5 mM Hepes, 85 mM KCl, 0.5% Nonidet
P40, Protease Inhibitor [Roche]). Nuclei were pelleted at 8,000
rpm for 10 minutes at 4?C and resuspended in immunoprecipita-
tion buffer (50 mM Tris-HCl pH 7.5, 150 mM KCl, 5 mM
MgCl2, 0.2 mM EDTA, 20% glycerol, protease inhibitor [Roche],
0.5 mM dithiothreitol), sonicated, and DNA was digested with
DNaseI (Roche). Immunoprecipitations were carried out using
200 mg of nuclear proteins and 2 mg of a-Sox2 (15830, Abcam)
for 2 hours at 4?C, followed by three washes in washing buffer
(20 mM Tris-HCl pH 7.5, 100 mM KCl, 5 mM MgCl2, 0.2 mM
EDTA, 10% glycerol, 0.1% Tween-20, protease inhibitor
[Roche]), and eventually resuspended in 13 SDS-loading buffer.
Chromatin Immunoprecipitation
WT, Artd12/2, and ABT-888 inhibited cells were crosslinked
with 1% formaldehyde (Calbiochem). Chromatin was fragmented
with the Bioruptor (Diagenode, Lie`ge, Belgium, http://www.dia-
genode.com), incubated with specific antibodies, and collected
with Protein A Agarose/salmon sperm DNA (Millipore). DNA
was extracted and measured by real-time PCR using SYBR Green
and Rotor-Gene 3000 (Corbett Life Science/QIAGEN). For
Primer sequences see Supporting Information Table S1.
RESULTS
Artd1 Is Necessary for Successful Initiation of
Reprogramming
MEFs were isolated from day 14 embryos obtained from homo-
zygous breeding of WT and Artd12/2 mice, respectively. WT
and Artd12/2 fibroblast were transduced with the Yamanaka
factors as previously described [13] and the number of iPSC-
colonies was assessed after 14 days of cultivation. The number
of iPSC colonies obtained upon reprogramming of Artd12/2
fibroblasts was reduced by around 65% compared to WT fibro-
blasts (Fig. 1A). These observations are in agreement with
recently published data [11] and indicate that Artd1 is required
for the reprogramming of somatic cells to iPSCs. An even
stronger reduction in the number of iPSC colonies (80%) was
observed when the PARP-Inhibitor ABT-888, which mainly
inhibits Artd1 and Artd2 [14], was applied. The small differ-
ence in the number of colonies between cells lacking Artd1 and
PARP-inhibitor treated cells might indicate that the contribution
of other ARTD family members than Artd1 during reprogram-
ming is minimal. In addition, the ABT-888 inhibitor did not
change the transcriptional levels of Artd1 and Artd2, indicating
that the effects observed are exclusively due to the inhibition of
the enzymatic activity (Supporting Information Fig. S1A, S1B).
In order to define if ADP-ribosylation is necessary during the
whole reprogramming process or only during a specific time
window, we added the ABT-888 inhibitor starting from days 0,
2, 4, 6, and 8 after the transduction of WT fibroblasts with the
Yamanaka factors. iPSC colony formation was strongly reduced
when the inhibitor was added during the first 4 days of reprog-
ramming, but unaffected if cells from later time points after
viral infection were treated (Fig. 1B), indicating that Artd1
enzymatic activity is essential during the early phase of the
reprogramming process. In order to determine the expression
changes of Artd1 and Artd2 during the first 12 days of reprog-
ramming, we performed quantitative real-time PCR analysis
(Fig. 1C, 1D). The expression of both Artd1 and Artd2 con-
stantly increased from day 2 to day 8 and dropped to levels
similar to the untreated control cells by day 12. This increase in
Artd1 expression was also observed at the protein level (Fig.
1E) and was in accordance with increased PARylation in fibro-
blasts at day 2, followed by a decrease at day 4 and a constant
level in the following days (Fig. 1F). In summary, our data
indicate an upregulation of Artd1 and Artd2 expression and of
PARylation during the first days of reprogramming. Blocking of
Artd1, either by genetic ablation or by applying a PARP-
inhibitor, drastically decreases the efficiency of reprogramming.
Artd1 Is Responsible for Poly(ADP-Ribosylation) of
Sox2 During Reprogramming
In ESCs, Artd1 was previously described to PARylate Sox2,
thereby decreasing the association of Sox2 with the Fgf4
enhancer and inducing Fgf4 expression [10]. In order to test
the capacity of Artd1 to PARylate Sox2, we transfected a
HA-Sox2 expression vector in HEK293 cells and the recombi-
nant protein was purified by immunoprecipitation. Upon in
vitro incubation of the purified protein with recombinant
human ARTD1 and radiolabeled NAD1, a signal at the pre-
dicted size of Sox2 was clearly detected, indicating that Sox2
is substrate of ARTD1 (Fig. 2A). To further prove that Sox2 is
PARylated during reprogramming, WT, WT1ABT-888, and
Artd12/2 day 4 cells were collected in high stringency ionic
buffer in order to reduce cellular protein complexes. Cleared
nuclear lysates were subsequently used to immunoprecipitate
PARylated proteins with an anti-PAR antibody. PARylated
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proteins were resolved in SDS-PAGE, followed by Western
blotting against Sox2 and Artd1. Sox2 as well as Artd1 were
pulled down in WT extract but not in WT1ABT-888 or
Artd12/2 extracts, indicating that Sox2 is a targeted by ADP-
ribosylation in vivo. (Fig. 2B) In order to assess the expression
pattern of Sox2 and the PARylation levels during the first
phase of reprogramming, we performed Western blotting of
Sox2 (Supporting Information Fig. S2) and monitored the
localization of Sox2 and PAR by immunofluorescence in WT
and Artd12/2 fibroblast at days 0, 2, 4, and 6 after viral infec-
tion with the Yamanaka factors (Fig. 2C and Supporting Infor-
mation Fig. S3). In the nuclei of WT fibroblasts PARylation
was detectable starting from day 2 post-transduction and was
still present at day 6. Interestingly, Sox2 staining mainly colo-
calized with the PAR signal, suggesting that ADP-ribosylation
of Sox2 occurs at the beginning of reprogramming. As
expected, a PAR signal was not detectable in the Artd12/2
fibroblasts at any time point, thus supporting the idea that Artd1
is the major ADP-ribosyltransferase involved in the process.
In order to clarify if in vivo, during the first phases of
reprogramming, Artd1 and Sox2 directly interact, WT and
Artd12/2 fibroblasts were transduced with the Yamanaka
Figure 1. Artd1 enzymatic activity is necessary for the initial steps of reprogramming. (A): Reprogramming efficiency in WT fibroblasts,
Artd12/2 fibroblasts, and WT fibroblasts treated with ABT-888. (B): Artd1 enzymatic activity is essential during the early phase of the reprog-
ramming process. ABT-888 was added at the indicated time points and the reprogramming efficiency was assessed. (C): Expression of Artd1 in
WT cells during the reprogramming process. (D): Expression of Artd2 in WT cells during the reprogramming process. (E): Expression levels of
Artd1 during reprogramming. Western blot for Artd1 on WT cells collected at the indicated time points during reprogramming. The smear of the
Artd1 signal reflects Artd1 activity. Tubulin has been used as a loading control. Molecular size references in kilo Daltons are indicated. (F):
PAR formation during reprogramming. Western blot for PAR on WT cells collected at the indicated time during reprogramming. Tubulin has
been used as a loading control. Molecular size references in kilo Daltons are indicated. Dunnett’s multiple comparison test. ns5 not significant,
**, p< .01; ***, p< .001; ****, p< .0001. Abbreviations: PAR, poly(ADP-ribose); WT, wild type.
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Figure 2. Artd1 binds and post-translationally modifies Sox2 during reprogramming. (A): Trans ADP-ribosylation of HA-Sox2 by recARTD1.
Recombinant human ARTD1 (10 pmol) was incubated with HA-Sox2 (lane 1), HA-empty (lane 2), or H1 as positive control (lane 3). Coomassie
blue stained gel (left), autoradiography (middle), and Western blot for Sox2 bound to the beads (right) are shown. (B): Sox2 ADP-ribosylation during
reprogramming. High stringent immunoprecipitation was carried on with either PAR antibody 10H or IgG control on nuclear extracts of WT, ABT-
888 treated WT, and Artd12/2 cells collected at day 4. Western blots of Sox2 and Artd1 in immunoprecipitation samples and inputs are shown. (C):
Immunofluorescence of Sox2 and PAR during reprogramming at day 4. WT and Artd12/2 cells were stained with DAPI, for Sox2 and for PAR.
Signals in the relative channels are shown from left to right. Merge of the three channels is also reported. Scale bar5 10 mm. (D): Sox2/Artd1 interac-
tion during reprogramming. Immunoprecipitation was carried on with either Sox2 antibody or IgG control on nuclear extracts of WT and Artd12/2
cells collected at the indicated time. Western blots of Sox2 and Artd1 in immunoprecipitation samples and inputs are shown. proliferating cell nuclear
antigen (PCNA) was used as indicator of equal starting protein content for the immunoprecipitations. Abbreviations: DAPI, 4?,6-diamidino-2-phenylin-
dole; ESCs, embryonic stem cells; Fibros, fibroblasts; WT, wild type.
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factors and protein extracts were isolated at day 4 and day 8
upon transduction. Artd1/Sox2 coimmunoprecipitation was
detectable at day 4 and day 8 in WT fibroblasts, clearly indi-
cating that these two proteins interact in reprogramming fibro-
blasts. As expected, in Artd12/2 fibroblasts, no interaction
was detectable (Fig. 2D). Taken together, our data show that
within the first 8 days of reprogramming, Artd1 interacts with
Sox2 and mediates its PARylation.
Artd1-Mediated ADP-Ribosylation of Sox2 Is
Responsible for the Activation of Fgf4 Transcription
Although Sox2 has been reported to bind to the Fgf4
enhancer element, its effect on Fgf4 transcription remains
controversial. Originally, it was described that Sox2 binding
enhances Fgf4 transcription [15]. In contrast, a more recent
study reported that in ESCs and in differentiating cells, Sox2
represses Fgf4 transcription and that ADP-ribosylation of
Sox2 relives Fgf4 repression [10]. In addition, the work of
Lai et al. showed that in ESCs, Sox2 positively regulates
Fgf4 transcription and that auto-modified Artd1 interacts with
Sox2, consequently inducing its release from the Fgf4
enhancer and repressing Fgf4 transcription [11]. To investi-
gate the role of Sox2, Artd1, and ADP-ribosylation in the
fine-tuning of Fgf4 transcription, we first analyzed the expres-
sion of Fgf4 upon initiation of reprogramming. In WT fibro-
blasts, expression of Fgf4 was detectable starting from day 2
and increased steadily until day 6. In contrast, in Artd12/2
as well as in WT fibroblasts treated with the ABT-888 inhibi-
tor, expression was strongly reduced and delayed. This clearly
indicates that the presence of Artd1 is necessary for the cor-
rect activation of Fgf4 transcription (Fig. 3A). In order to
assess the binding capacity of Sox2 to the Fgf4 enhancer, we
performed ChIPs using antibodies against Sox2 during reprog-
ramming in WT, Artd12/2, and in WT fibroblasts treated
with ABT-888. As depicted in Figure 3B, during the reprog-
ramming process, Sox2 is recruited to the Fgf4 enhancer and
to other target sites such as the Nanog promoter. In ABT-888
inhibited fibroblasts, Sox2 recruitment is delayed, which is in
agreement with the lower transcription of Fgf4 (Fig. 3A),
indicating that PARylation positively influences the DNA
binding capacity of Sox2. Strikingly, the delay of Sox2
recruitment in the presence of ABT-888 is phenocopied in
Artd12/2 cells (Fig. 3B), confirming that Artd1 is mainly
responsible for Sox2 ADP-ribosylation in reprogramming
cells. Taken together, our data demonstrate that ADP-
ribosylation of Sox2 strengthens the binding of Sox2 to its
target sites and thereby stimulates the transcription of the cor-
responding target genes.
Fgf4 Expression Is Crucial for the Initiation of
Reprogramming
The reduced transcription of Fgf4 in Artd12/2 fibroblasts
upon the initiation of reprogramming leads to the question if
the impaired reprogramming efficiency of Artd12/2 cells is
the direct consequence of the reduced Fgf4 levels or if other
factors are involved. We therefore repeated the reprogram-
ming experiments in WT and Artd12/2 fibroblast by adding
10 ng/ml and 25 ng/ml of exogenous Fgf4 to the cells. Addi-
tion of 10 ng/ml of Fgf4 was sufficient to restore the reprog-
ramming efficiency to comparable levels as in WT cells (Fig.
4A), indicating that the phenotype observed in Artd12/2
cells is due to an insufficient expression of Fgf4 during the
early stages of reprogramming. Interestingly, higher amounts
of Fgf4 (25 ng/ml) or addition of exogenous Fgf4 to WT
fibroblast rather impaired the reprogramming efficiency, sug-
gesting that a tight control of autocrine Fgf4 production is
essential for the initiation of reprogramming. The Artd12/2
iPSC colonies obtained upon addition of Fgf4 could be
expanded for more than 10 passages and expressed the classic
pluripotency genes. Furthermore, they were able to differenti-
ate in vitro toward smooth muscles and neurons and showed
no differences from WT and Artd12/2 iPSCs (Supporting
Information Fig. S4).
The fact that Fgf4 transcription depends on ADP-
ribosylation of Sox2 and the capacity of exogenous Fgf4 to
restore the reprogramming efficiency in Artd12/2 fibroblasts
suggests that the enzymatic activity of Artd1 is essential for
the initiation of reprogramming. To test this, we reprog-
rammed WT fibroblasts and cultivated the cells for the first 2,
4, or 6 days with ABT-888 or with ABT-888 and 10 ng/ml
Fgf4. The addition of Fgf4 for the first 2 or 4 days abolished
the inhibitor effect of ABT-888 and significantly increased
the reprogramming efficiency (Fig. 4B), indicating that the
direct addition of Fgf4 compensates for the absence of ADP-
ribosylation activity. This strengthens the observation that
Artd1-mediated ADP-ribosylation of Sox2 is essential to mod-
ulate Fgf4 transcription during the initial phases of reprog-
ramming. To further prove the importance of Fgf4, we
performed Fgf4 knockdown experiments. The combination of
viral transduction of the reprogramming factors with knock-
down induced massive cell death in the fibroblast. This was
not due to Fgf4 knockdown itself because scrambled controls
had the same effect. We therefore decided to inhibit Fgf
receptor tyrosine kinases with small chemical inhibitor
SU5402 [16] in WT cells. The inhibition of Fgf receptor tyro-
sine kinases reduced the reprogramming efficiency of WT
fibroblasts by around 50% (Fig. 4C). In summary, our results
clearly identify Artd1-mediated ADP-ribosylation of Sox2 as
an essential component for the correct activation of Fgf4
expression, which in turn plays a crucial role for the initiation
of the reprogramming process.
DISCUSSION
Cell differentiation is normally an irreversible process and
differentiated cells are not able to switch from one lineage to
another. Cellular reprogramming to pluripotency therefore
requires that pluripotency genes, which are inactive in differ-
entiated cells, are reactivated. Exogenously introduced reprog-
ramming factors must therefore bind and reactivate their
target genes in tight collaboration with other endogenous fac-
tors, particularly epigenetic regulators.
In this work, we aimed at understanding the function of
the well-known epigenetic regulator Artd1 during the first
phase of reprogramming. Artd1 was previously shown to be
necessary for proper differentiation of ESCs [8]. Even though
Artd1 deficiency does not affect the growth of ESCs, its
absence compromises cell survival and growth when ESCs
are induced to differentiate [8,10]. The molecular mechanisms
underlying this observation are still largely unclear, but new
studies indicate that Artd1 acts as a cofactor of Oct4 and
Sox2 in ESCs by binding to the Fgf4 enhancer and thereby
regulates Fgf4 expression [10,11]. The major function of Fgf4
in pluripotent cells is to regulate the selection between the
alternative fates of self-replication and lineage commitment
during continuous proliferation. Autocrine production of Fgf4
is the major stimulus activating the Erk1/2 signaling cascade
in na?ıve mouse ESCs [17,18]. Inhibiting ERK and FGF activ-
ity with small chemical compounds prevents ESCs from dif-
ferentiating without affecting the propagation of the
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Figure 3. Artd1 activity is necessary for the binding of Sox2 to the Fgf4 enhancer and for driving Fgf4 expression. (A): Expression of Fgf4
during the reprogramming process in WT fibroblasts6ABT-888 and Artd12/2 fibroblasts. (B): Recruitment of Sox2 to target genes: chromatin
immunoprecipitation was carried on with either Sox2 antibody or IgG control in WT, Artd12/2, and ABT-888 inhibited cells at the indicated
time points. Recruitment of Sox2 to the Fgf4 enhancer, the Nanog promoter, and the unrelated Rps6 promoter is depicted. Values are expressed
as enrichment over input signals. Abbreviation: WT, wild type.
2370 Parp1/Sox2 Regulation of Fgf4 During Reprogramming
 Results 
 33 
undifferentiated ESCs [18,19]. Similarly, ESCs lacking Fgf4
are resistant to neural and mesodermal induction, but are able
to commit when FGF is provided exogenously [18].
During differentiation of ESCs, Artd1 was shown to
directly interact with and to PARylate Sox2, leading to the dis-
sociation and degradation of Sox2 from the Fgf4 enhancer. This
releases Sox2 inhibition and induces Fgf4 gene transcription
[10]. In the absence of activated Artd1, Sox2 cannot be ADP-
ribosylated, augmenting its interaction with the Fgf4 enhancer
and leading to a stabilization of Sox2 protein and a reduction in
Fgf4 levels [10]. An alternative model suggests that Artd1 auto-
PARylation enhances Sox2-Artd1 interactions and inhibits
binding of Sox2 to the Oct4/Sox2 site at the Fgf4 enhancer.
This process seems to be regulated by FGF/ERK signaling [11].
We first tested the reprogramming capacity of Artd1
knockout cells and found that the absence of Artd1 strongly
reduces the number of iPSC colonies. We could also identify
that the critical time period during which Artd1 activity is
necessary are the first 2–4 days after transduction with the
reprogramming factors. This is in agreement with the
increased expression of Artd1 starting at day 2 after reprog-
ramming and the concomitant increase of PARylation. The
reduction of the reprogramming efficiency is mainly due to
the lack of Artd1 activity and not of other members of the
ARTD family, because the treatment of WT fibroblasts with
ABT888, an inhibitor of poly(ADP-ribosyltransferases),
mimics the genetic ablation of Artd1. We further observed a
strong delay in Fgf4 expression upon the initiation of reprog-
ramming in Artd12/2 fibroblasts or when WT fibroblasts are
treated with ABT-888. Fgf4 expression occurs much earlier
than the activation of transcription of other typical pluripo-
tency markers such as Nanog, SSEA-1, or OCT-4. This obser-
vation is interesting because Fgf4 is typically expressed in
pluripotent cells [18,20,21] and not in fibroblasts.
Figure 4. Exogenous Fgf4 supplementation is sufficient to restore the reprogramming capacity in Artd12/2 fibroblasts and WT cells treated
with ABT-888 inhibitor. (A): Reprogramming efficiency of Artd12/2 cells cultivated with exogenously added Fgf4. (B): Reprogramming effi-
ciency of WT1ABT-888 cells in the presence or absence of Fgf4. WT fibroblasts were treated for the first 2, 4, or 6 days with ABT-888 alone
or ABT-888 and 10 ng/ml Fgf4. (C): Reprogramming efficiency in WT cells and WT cells treated with SU5402, an inhibitor of Fgf receptor
tyrosine kinase activity. (D): Schematic representation of Artd1-mediated PARylation of Sox2 and binding to the Fgf4 enhancer, which activates
Fgf4 expression. Dunnett’s multiple comparison test (A) and Student’s t test (B, C). ns5 not significant, *, p > .05; **, p< .01; ****, p< .0001.
Abbreviation: WT, wild type.
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Based on previous studies [10,11] indicating a role of Artd1
in modulating Sox2 activity in the context of Fgf4 regulation,
we decided to analyze the capacity of Artd1 to modify Sox2 in
vitro and in vivo. Our data demonstrate that human ARTD1 is
able to PARylate Sox2 in vitro and strongly suggest that murine
Artd1 mediates ADP-ribosylation of Sox2 in vivo in fibroblasts
starting from day 2 during reprogramming. The role of Sox2 in
the regulation of Fgf4 transcription is also highlighted by the
observation that ADP-ribosylation of Sox2 increases its binding
to the Fgf4 enhancer and leads to increased transcription. In
summary, our data confirm that during the early phase of the
reprogramming process, Artd1-mediated ADP-ribosylation of
Sox2 is necessary for the binding of Sox2 to the Fgf4 enhancer
and for inducing Fgf4 expression, which in turn is responsible
for initiating the further events leading to the formation of
iPSCs.
The importance of Fgf4 during the first phase of the
reprogramming process is strengthened by the fact that
Artd12/2 fibroblasts, which show a strongly reduced activa-
tion of Fgf4 upon reprogramming initiation, show a massive
reduction in the number of iPSC colonies. The simple addi-
tion of Fgf4 during this time is sufficient to restore the
reprogramming efficiency to comparable levels as in WT
cells, indicating that Fgf4 is functionally the only factor regu-
lated by Artd1 during the early phase of reprogramming (Fig.
4A). A similar effect can be observed when WT fibroblasts
are cultivated in the presence of the ABT-888 inhibitor. Also
in this case the simple addition of Fgf4 to the medium is suf-
ficient to restore the reprogramming efficiency (Fig. 4B). The
importance of Fgf4 during the early phase of reprogramming
is also corroborated by the fact that WT cells treated with an
inhibitor of Fgf receptor tyrosine kinases, which are normally
activated upon the binding of Fgf, reduces the reprogramming
efficiency by 50% (Fig. 4C).
Of interest, Artd1 in conjunction with 10–11
translocation-2 (Tet2) was recently shown to play an impor-
tant role in the early stages of somatic cell reprogramming by
mediating the histone modifications necessary for the estab-
lishment of an activated chromatin state at pluripotency loci
(e.g., Nanog and Essrb) [12]. Furthermore, Artd1 induction
promotes accessibility to the Oct4 reprogramming factor.
Interestingly, pluripotency factors are detectable starting
around days 10–12 of the reprogramming process [22–25],
which would suggest that Artd1 might have two different
functions. In the first phase (first week) of the reprogramming
process, Artd1 is required for initiating the transcription of
Fgf4. In a second step, Artd1 might be involved in promoting
the accessibility of the reprogramming factors to the pluripo-
tency gene promoters as shown by Doege et al. [12]. Since
we did not observe an effect of PARP inhibitors on the
reprogramming efficiency at this time point, it is fair to
assume that this process is independent of ADP-ribosylation.
Furthermore, our data demonstrate that even in the absence of
Artd1, exogenously supplied Fgf4 permits reprogramming
efficiencies as for WT fibroblasts, indicating that in the
ARDT12/2 cells additional epigenetic modifiers must be
interacting with Tet2 to mediate the histone modifications
necessary for the activation of pluripotency genes.
CONCLUSIONS
Our data indicate that PARylation of Sox2 by Artd1 plays an
important role in the generation of iPSCs. Artd1-mediated
PARylation of Sox2 favors its binding to the Fgf4 enhancer,
thereby activating Fgf4 expression (Fig. 4D). Exogenous addi-
tion of Fgf4 during the first 4 days upon initiation of reprog-
ramming was sufficient to restore the reprogramming capacity
of Artd1 knockout fibroblast to WT levels, indicating that
Fgf4 is an essential component for the correct initiation of the
reprogramming process.
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Supplementary Figure 1. PARP-inhibitor do not change the transcriptional levels of Artd1 or Artd2. (A): 
Artd1 expression in wild-type (wt) cells, PARP-inhibited (ABT-888) cells and Artd1 knock-out cells (B): 
Artd2 expression in wild-type (wt) cells, PARP-inhibited (ABT-888) cells and Artd1 knock-out cells 
Artd1 
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Supplementary Figure 2. Artd1 knock out or inhibition of ADP-ribosylation do not change Sox2 
protein levels. (A): Sox2 western blot in reprogramming wild-type (wt) or Artd1 knock-out (Artd1-/-) 
fibroblasts. (B): Sox2 western blot in reprogramming wild-type (wt) or PARP-inhibited (ABT-888) 
fibroblasts. Tubulin was used as loading control.  
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Supplementary Figure 3. Artd1 is necessary for the reprogramming-induced PAR formation. (A): Sox2 
and PAR immunofluorescence at different time points during reprogramming. DAPI was used as nuclear 
marker. 
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Supplementary Figure 4. Reprogrammed ARTD1-/- fibroblasts with exogenous Fgf4 administration  are 
pluripotent and able to differentiate to smooth muscles and neurons. (A): Oct4 and SSEA1 
immunofluorescence of wild-type (wt), Artd1 knock out (Artd1-/-) and Artd1 knock out with exogenous 
administration of Fgf4 (Artd1-/- Fgf4) iPS cells (B): Oct4, Sox2, Nanog and Rex1 expression in wild-type 
(wt), Artd1 knock out (Artd1-/-) and Artd1 knock out with exogenous administration of Fgf4 (Artd1-/- 
Fgf4) (C): SMA and ?III-tubulin immunofluorescence of wild-type (wt), Artd1 knock out (Artd1-/-) and 
Artd1 knock out with exogenous administration of Fgf4 (Artd1-/- Fgf4) iPS cells  
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Abstract 
Chromatin ADP-ribosylation is catalyzed by diphtheria toxin-like ADP-
ribosyltransferases (ARTDs). However, the lack of suitable methods has so far 
prevented genome-wide analysis of chromatin ADP-ribosylation. We have therefore 
developed a novel chromatin affinity precipitation (ChAP) technique based on the 
affinity of two poly-ADP-ribose binding domains (WWE of RNF146 and 
macrodomain Af1521) to map poly-ADP-ribosylation of chromatin regions at the 
genome-wide scale. ChAP performed on oxidatively stressed A549 epithelial cells 
revealed that chromatin ADP-ribosylation is associated with SINE and LINE, as well 
as alpha satellite repetitive elements. Interestingly, ADP-ribsylation was associated 
with hetero- rather than euchromatin and with enhanced accessibility to the DNA. 
Moreover, application of the ChAP in differentiating adipocytes revealed that 
chromatin ADP-ribosylation predominantly localizes at promoters of PPAR! target 
genes. Together, this method allows investigating how ADP-ribosylation regulates 
chromatin plasticity and functions during biologically important processes.  
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Introduction 
Protein ADP-ribosylation is an ancient and reversible post-translational protein 
modification with high biochemical complexity (linear and/or branched) that 
comprises the transfer of the ADP-ribose moiety from NAD+ to specific amino acid 
residues on substrate proteins or to ADP-ribose itself, generating protein poly-ADP-
ribosylation. ADP-ribosylation is primarily governed by ADP-ribosyltransferases (22 
mammalian enzymes identified so far), recognized by different protein domains and 
thus also serve as a scaffold for the recruitment of proteins during complex formation 
('readers'), and de-modification by ADP-ribosylhydrolases ('erasers'). Among the 
described readers, some specifically recognized mono-ribosylated (MARylated) and 
poly-ADP-ribosylated (PARylated) proteins (e.g. macrodomain Af1521), while other 
bind only PARylated proteins (e.g. WWE domain). MARylation or PARylation alters 
the function of modified proteins or provides a scaffold for the recruitment of other 
proteins and thus regulates several cellular processes51. From the existing 18 
intracellular ARTDs (ART diphteria toxin-like), ARTD1 is found exclusively in the 
nucleus while the other ARTDs are found in the nuclear as well as in the cytoplasmic 
or only in the cytoplasmic compartment. Interestingly, most if not all poly-ADP-
ribose (PAR) chains are found on nuclear proteins127. In general, the currently 
detectable nuclear PAR formation mainly seems to be induced as a response to stress 
signaling, and the intensity of ADP-ribosylation seems to correlate with the intensity 
of the signal128.  
 Cellular studies have shown that ARTD1 is recruited to eu- as well as 
heterochromatin. The earliest studies have focused on the activation of ARTD1 
enzymatic activity by DNA lesions induced by exogenous stimuli such as hydrogen 
peroxide (H2O2). H2O2 treatment is assumed to introduce DNA lesions randomly 
especially in open euchromatin129. In contrast, there are also recent indications that 
nuclear PARylation by ARTD1 is induced upon a very targeted process, e.g. DNA 
cleavage by DNA topoisomerase II " (TopoII") during transcription130, or DNA 
lesion-independent mechanisms (reviewed in131).  
All canonical histones are covalently ADP-ribosylated predominantly at the basic 
amino-terminal regions, although the extent of ADP-ribosylation depends on the 
chromatin status and the tested conditions (reviewed in132). In general, it is difficult to 
detect and localize histone ADP-ribosylation in vivo because only a small fraction of 
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the total histones is modified (a few percent). Thus, developing techniques that can be 
used to localize and characterize the sites of chromatin ADP-ribosylation in cells 
during different conditions is critical for further understanding the function of 
chromatin-associated ADP-ribosylation. 
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Results and Discussion 
Immunoaffinity precipitation with mono- or polyclonal antibodies against poly-ADP-
ribose (PAR) have been used to capture PARylated proteins for their subsequent 
identification133,134, and to visualize PARylation by immunohistochemistry. However, 
due to the very poor affinity of these antibodies for formaldehyde-fixed extracts, 
PARylation of chromatin cannot be reproducibly localized with the conventional 
chromatin immune precipitation (ChIP) protocol or require cell-type specific 
optimizations of the protocols to reduce the high background. We therefore developed 
a new and robust method to identify chromatin-associated protein PARylation at 
defined loci and for whole genome analysis by combining chromatin affinity 
precipitation (ChAP) with qPCR, high-throughput sequencing or ChIP (Fig. 1a). 
The wild-type WWE domain of the ubiquitin ligase RNF146 and the macrodomain 
Af1521 from archaebacteria, expressed as GST-fusion protein and bound to 
glutathione beads, very specifically pull down in vitro PARylated ARTD1 and H3 
compared to their mutated counterpart (Fig. 1b). Moreover, only PARylated proteins, 
but not proteins MARylated by ARTD10, bound to the RNF146 WWE domain 
(Supplementary Fig. 1a-c). To investigate chromatin-associated ADP-ribosylation, 
A549 cells were either mock-treated or exposed to a sublethal dose of hydrogen 
peroxide (H2O2) (Supplementary Fig. 2a). Detection of H2O2-induced PAR formation 
by immunofluorescence, or pull down experiments using the RNF146 WWE domain 
and subsequent detection of PAR by immunoblotting was only possible when cells 
were fixed with 4% formaldehyde, a concentration that, compared to 1% 
formaldehyde, importantly also inhibits lysis-induced PAR-formation and prevents 
PAR degradation during cell lysis (Supplementary Fig. 2b-d, 135). The isolated 
chromatin was then sonicated to approximately 150-250 bp fragments and 
subsequently enriched using either the RNF146 WWE domain or the macrodomain 
Af1521. Using these conditions, both domains selectively enriched the 4% 
formaldehyde-fixed ADP-ribosylated chromatin fraction, which contained ARTD1 
(Fig. 1c and Supplementary Fig. 3a). Importantly, enrichment of the chromatin 
fraction was very specific, since the PAR signal was only observed when cells where 
treated by H2O2, could only be detected with the wild-type but not mutant RNF146 
WWE or macrodomain Af1521 and was dependent on protein ADP-ribosylation, as 
the signal was completely abrogated by pretreatment of the cells with the ADP-
ribosylation inhibitor ABT-888 (Fig. 1c).  
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To test whether the RNF146 WWE domain can be successfully used to pull down 
ADP-ribosylated chromatin and allowing subsequent analysis of the underlying DNA 
by qPCR, the RNF146 WWE-enriched chromatin fraction from mock- and H2O2-
treated cells was analyzed for three regions with different chromatin features: the 
transcription start site (TSS) of the house keeping gene GAPDH, representing a 
euchromatic region with active histone marks, the promoter of the IL1! gene 
representing a compacted chromatin region with repressory histone marks and the 
heterochromatic alpha satellite (#SAT) regions (Fig. 1d and Supplementary Fig. 3b-
d). The analysis revealed that only upon H2O2 treatment the wild-type, but not the 
ADP-ribose binding-deficient mutant WWE domain allowed the amplification of the 
indicated DNA regions, strongly suggesting that these chromatin loci are ADP-
ribosylated. Moreover, while only very little ADP-ribosylation was observed at the 
TSS of the expressed GAPDH, a higher signal was observed for the IL1! promoter, 
and a very strong signal was obtained for the heterochromatic alpha satellite regions, 
suggesting that the extent of ADP-ribosylation depends on the chromatin context (Fig. 
1d). Similar results were obtained using the macrodomain Af1521, although the ADP-
ribosylation levels where higher at the TSS of GAPDH, which may be due to the fact 
that the macrodomain Af1521 detects PARylated and MARylated proteins 
(Supplementary Fig. 3e). The same experiments with the 4% formaldehyde fixed 
chromatin, but using two currently available anti PAR antibodies revealed that also 
under these conditions, where induced PAR formation is prevented from degradation, 
the ChIP signals were not specific, since also a signal for ABT-888 treated samples 
was detected or even higher compared to non-inhibitor treated samples 
(Supplementary Fig. 4a and b). Interestingly, a ChAP signal was retrieved solely at 10 
min after cell stimulation, while the signal already dropped down to background after 
30 min of H2O2 stimulation, in line with the rapid decay of H2O2-induced ADP-
ribosylation as observed by immunofluorescence (Supplementary Fig. 5a). Moreover, 
the intensity of the ChAP signal was dependent on the H2O2 concentration used, 
indicating that quantitative changes in chromatin ADP-ribosylation can be detected by 
the novel technique (Supplementary Fig. 5b). 
The observed increase in ChAP signal induced by H2O2 was specific for ADP-
ribosylation, since co-treatment of cells with ABT-888 completely abrogated the 
enrichment (Fig. 1e). Furthermore, to test the contribution of ARTD1 to the detected 
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signal, we knocked down ARTD1 by shRNA transduction before stimulating the cells 
with H2O2. All signals detected in the 3 different regions assessed were strongly 
reduced to background by ARTD1 knock-down, illustrating the key role of ARTD1 in 
PAR induction after H2O2 and further demonstrating the high specificity of the 
method (Fig. 1e). To gain further insight into the composition of the chromatin 
associated with ADP-ribosylated proteins, we analyzed the chromatin association of 
ARTD1 by conventional ChIP or by ChAP-ChIP the material from Fig. 1d (after 
releasing it from the beads by SDS) with antibodies specifically immunoprecipitating 
ARTD1 (Fig. 1f). These experiments clearly demonstrated that ARTD1 was 
associated with the ADP-ribosylated chromatin, indicating that the H2O2-induced and 
ARTD1-mediated PARylation did not repel it from the chromatin under the tested 
conditions. Comparable analysis for H3 revealed that H3 remained also associated 
with the chromatin under the tested conditions (Fig. 1g) and that ADP-ribosylation is 
associated to regions with high ARTD1 and nucleosome content (Fig. 1f and g). To 
investigate the functional consequence of chromatin ADP-ribosylation, we treated 
cells with H2O2 in presence or absence of ABT-888 and tested the DNA accessibility 
at the same chromatin loci using CHART-PCR136. ADP-ribosylation substantially 
increased the accessibility for the MNase digestion, indicating that ADP-ribosylation 
reduced chromatin compaction and increased accessibility at the sites of chromatin 
ADP-ribosylation (Fig. 1h). 
 To define the genome-wide ADP-ribosylation signature induced by H2O2, we 
performed a ChAP-Seq experiment. The isolated DNA was deep sequenced after a 
ChAP and the retrieved reads filtered and computed in order to define peaks of ADP-
ribosylated chromatin. No significant peak was identified under unstimulated 
conditions, indicating that either no PARylation is present in cells under basal 
conditions or that the amount is too low to be detectable (Fig. 2a upper panel). 
However, upon H2O2 treatment, the high-throughput sequencing analysis identified 
6’633 unique peaks with an average size of 500 bp (Fig. 2d lower panel, b and c). 
ChAP-qPCR analysis using the macrodomain AF1521 covering up to 10 kb up- or 
downstream of an assigned peak confirmed that the detected chromatin ADP-
ribosylation peaks indeed covered only a distinct chromatin region (Fig. 2d). 
 While the vast majority of the peaks were located in intergenic regions and 
introns, only few peaks fell into TSSs, promoters or exons, indicating that H2O2-
induced ADP-ribosylation occurs less in these regions close to genes (Fig. 2e). When 
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analyzing the underlying sequences, chromatin ADP-riboslyation was mainly found 
to be associated with SINE, LINE or #SAT repetitive elements (137, Fig. 2f). 
Enrichment of the latter mirrored our ChAP-qPCR data, where the highest ChAP 
signals were also obtained for #SAT (Fig. 1d; Supplementary Fig. 3e).  
 To further explore the applicability of the new ChAP technique for a different 
cell type and addressing another biologically important questions, we characterized 
chromatin ADP-ribosylation in cells undergoing adipogenesis. We have recently 
reported that the inhibition of ADP-ribosylation or depletion of ARTD1 severely 
hampers PPAR!-dependent gene expression in differentiated 3T3L1 cells 138. When 
we applied the ChAP method to differentiated adipocytes, we were able to 
specifically enrich ADP-ribosylated chromatin fragments containing nucleosomes 
(i.e. H3), ARTD1 and protein-associated PAR (Fig. 3a). Further analysis of the DNA 
associated with the ADP-ribosylated chromatin revealed a high PAR signal on the 
PPAR!-response elements of PPAR! target genes such as aP2 and adiponectin and no 
such signal for CD36 or K19, a control gene not dependent on PPAR! (Fig. 3b), 
indicating that not all promoters of PPAR! target genes are ADP-ribosylated to the 
same extent or at the same time. Over night pretreatment of adipocytes with ABT-888 
prevented any enrichment, confirming again that the enriched chromatin was ADP-
ribosylated and that the ChAP method was also specific using this cellular system 
(Fig. 3b). ChIP analysis of ARTD1 and PPAR! on aP2 revealed that ARTD1 and 
PPAR! are both recruited to the aP2 promoters during differentiation (Fig. 3c, d0 
versus d7). ChAP-ChIP analysis of the same regions revealed that while ARTD1 
levels were unchanged, a strong increase of PPAR! binding to the ADP-ribosylated 
aP2 promoter was observed, indicating that chromatin ADP-ribosylation helps 
recruiting PPAR! to this promoter site (Fig. 3d). This was not the case for CD36, a 
gene less associated with PARylation (Fig. 3b-d). 
 In summary, we developed a novel highly specific method allowing genome-
wide ADP-ribosylated chromatin regions to be identified in different cellular 
paradigms of ADP-ribosylation induction. The specificity of the developed PAR-
ChAP method was shown i) by detecting a PAR-specific ChAP signal only, when 
PAR formation was induced in cells, ii) by enrichment only with the wild-type 
RNF146 WWE domain or the macrodomain Af1521, but not with mutants harboring 
single mutants abrogating binding to ADP-ribosylation and iii) by loosing the signal 
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upon treatment of the cells with the ADP-ribosylation inhibitor ABT-888 or knocking 
down the ARTD1, the enzyme responsible for PAR formation under the tested 
conditions. We expect that the identification of ADP-ribosylated chromatin loci using 
this new methodology will significantly promote the discovery of new insights into 
how ARTD1 regulates chromatin plasticity during different biologically important 
processes.  
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Methods 
In vitro ADP-ribosylation: Auto-modifications assays were performed as previously 
described138. Briefly: ARTD1, ARTD2 or ARTD10 were incubated with the reported 
concentration of [32P]NAD+ (PerkinElmer) or 100 )M cold NAD+ for 1 h at 30°C; 
ADP-ribosylated proteins were incubated together with WWE domain (see ChAP 
chapter); resolved on SDS-page and either exposed on X-ray films ([32P]NAD+) or 
immunoblitted with the reported antibodies. Trans ADP-ribosylation of histones was 
carried out adding to the ARTD1 reaction 1 )g of histones mix (Roche 
10223565001). 
 
GST-bait expression: BL21 competent E. coli cells were transformed with a GST-
WWE or GST-Af1521 coding plasmid and grew in LB medium and resistance till OD 
reached 0.5. Cells were induced with 100 )M IPTG and incubated for additional 3h at 
30°C. Bacteria were then lysed in M buffer 750 (50 mM Tris-HCl pH 8, 750 mM 
NaCl, 0.1% NP-40, 5 mM EDTA, proteinase inhibitor (Roche)) through French press; 
lysates were cleared by ultra centrifugation and GST-baits were quantified on SDS-
page using BSA as standards. 600 )l slurry glutathione magnetic beads (Pierce) were 
incubated with 2 mg GST-bait in M buffer 750 for 3 h; washed then 3 times in M 
buffer 750 (5 min each); 1x wash-2 (see ChIP chapter); eventually resuspended in 1 
ml of M buffer 500 (50 mM Tris-HCl pH 8, 500 mM NaCl, 0.1% NP-40, 5 mM 
EDTA) and stored at 4°C. 
 
Cells culture and treatment: A549 cells and 3T3L1 cells were maintained in 
Dulbecco's Modified Eagle's Medium (DMEM) (PAA, supplemented with 1% (v/v) 
Penicillin/Streptavidin and 10% (v/v) fetal calf serum (Gibco). shMock and shARTD1 
cells were generated as previously described 90 and maintained in medium with 1.5 
)g/)l puromycin (Puromycin). A549 cells were treated in PBS with 1mM (when not 
otherwise stated) H2O2 (Sigma) and incubated for 10 min. before proceeding with 
downstream protocols. Cells inhibited with PARP-inhibitor were preincubated with 
1)M ABT-888 (ENZO) for 30 min. and H2O2 stimulation was carried out in the 
presence of fresh inhibitor. 3T3L1 cells were differentiated as previously described138 
and processed at d7. 3T3L1 cells inhibited with PARP-inhibitor were preincubated 
with 1)M ABT-888 12 h before collection.  
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Immunofluorescence:. 1x105 A549 cells were seeded on coverslips; 24 h later 
treated in H2O2 and processed as previously described139. 
 
Antibodies: anti-PAR 10H (home made); anti-PAR (ALX-210-890) (ENZO); anti-
PARP (sc-7150) for western blot, anti-PPAR! rb (2443S), GST (Z-5), normal rabbit 
IgG (Santa Cruz); anti-PARP (46D11) for ChIP (Cell Signaling); histone H3 
(Abcam); acetyl-Histone H4, trimethyl-HistoneH3 (Lys27), trimethyl-HistoneH3 
(Lys9) (07-442) (Millipore); acety-Histone H3 (Upstate).  
 
Chromatin immuno precipitation (ChIP):. 1x15cm dish containing 4x106 A549 
cells (over night seeding) or confluent 3T3L1 per each condition were used. Cells 
were crosslinked in cold PBS containing 4% formaldehyde (Sigma) for 10 min. at 
4°C; washed in cold PBS; and collected in 1ml of cold lysis buffer (50 mM Tris HCl 
pH 8, 400 mM NaCl, 1% Triton-X, 5 mM EDTA, 1% SDS). A549 cells were lysed 
one time whereas for 3T3L1 it was necessary to repeat the lysis step 5 times with 3 
min. 5k g centrifugation in between in order to get rid of the cytoplasmic lipids. Cell 
pellet was then resuspended in D buffer (50 mM Tris HCl pH 8, 1% SDS, 5mM 
EDTA) and chromatin fragmented to 150-250 bp through sonication (Bioruptor). 
Chromatin was then cleared of debris by 10 min. centrifugation at 7k rpm at room 
temperature; and quantified as follow: 2 )l cleared chromatin were diluted in 18 )l 
TE buffer containing 20 U of proteinase K; reactions were incubated at 37°C for 1h; 
DNA was quantified with NanoDrop (Thermo Scientific) and run on agarose gel to 
check shearing efficiency. 3 )g of chromatin were saved as input and 30 )g per pull-
down were diluted in ChIP buffer (20 mM Tris-HCl pH 8, 150 mM NaCl, 2 mM 
EDTA, 0.01% SDS, 1.1% Triton-X, proteinase inhibitor (Roche)); incubated with 2 
)g of the reported antibody over night; and the following morning 10 )l of Protein A 
Dynabeads (life Technologies) were added and incubated for additional 4h. Following 
binding, beads were washed 2x wash-1 (0.1% SDS, 1% Triton X, 2 mM EDTA, 150 
mM NaCl, 20 mM Tris-HCl pH8), 1x wash-1high salt (0.1% SDS, 1% Triton X, 2 
mM EDTA, 500 mM NaCl, 10 mM Tris-HCl pH 8), 2x wash-2 (0.25 M LiCl2, 0.5% 
NP-40, 1 mM EDTA, 0.5% Na-deoxycholate) and 2x TE (10 mM Tris-HCl pH 8, 5 
mM EDTA). Protein-DNA complexes were digested on beads in 250 )l of buffer D 
supplemented with 400 mM (NaCl) and 20 U proteinase K for 1 h shaking at 42°C 
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and decrosslinked over night at 65°C. DNA was then extracted with phenol-
chloroform; precipitated in ethanol; resuspended in water and analyzed by real-time 
PCR using SYBR Green and the Rotor-Gene 3000 (Qiagen). 
 
Chromatin affinity precipitation (ChAP): The following description refers to a 
single pull down, cells and reagents were scaled up accordingly in case more 
reactions were carried out simultaneously. 1x15 cm dish containing 4x106 A549 cells 
(over night seeding) or confluent 3T3L1 were processed as for ChIP: cells were 
crosslinked in 4% formaldehyde; lysed in lysis buffer; chromatin was resuspended in 
200)l of buffer D; sonicated; and cleared of debris (all these steps as in ChIP 
chapter). Chromatin was then diluted in 10 ml of cold M buffer 500 (50 mM Tris-HCl 
pH 8, 500 mM NaCl, 0.1% NP-40, 5 mM EDTA, proteinase inhibitor (Roche)) and 
incubated for 3h together with 100)l beads-bound GST-WWE or GST-Af1521. After 
binding, beads were washed 1x in M buffer 500 followed by washes as reported in the 
ChIP chapter. 
 
ChAP-WB: Proteins were released from beads and protein complexes decrosslinked 
by boiling in Laemmli-buffer for 30 min. 
 
ChAP-qPCR: Protein-DNA complexes were eluted and processed as described in the 
ChIP chapter. 
 
ChAP-Seq: 1 ng of purified DNA (or the corresponding volume for the negative 
control samples) was used to generate barcoded library using Ovation Ultralow 
Library Prep kit (NuGen) according to manufacture protocol. Hybridized DNA was 
sequenced on Illumina HiSeq 2000 platform to generate paired-end 100 bp reads. 
Raw reads were aligned to the human genome (hg19 assembly) using Bowtie2, 
allowing one mismatch in the seed region of 31 nt and selecting the best alignment 
based on alignment scores in case of multiple hits. PCR duplicates were identified and 
discarded using Picard. The resulting read alignments were used to identify genomic 
regions with significant read enrichments (peaks) using the HOMER software in both 
factor and histone mode to statistically test for enrichments in narrow and broad 
genomic regions, respectively. The peak calling procedure was carried out by 
comparing the wild-type VS mutant samples, considered as background. To quantify 
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read enrichment within different classes of repetitive elements the genomic 
coordinates of different classes of repetitive elements spanned by the UCSC genome 
browser RepeatMasker were retrieved and used to construct a Bowtie index of 
repetitive sequences. The reads of each sample were aligned to this new reference. A 
read was only counted once per class regardless if it aligned to multiple sequences 
within the same class. GO analysis was performed using DAVID software140. 
 
ChAP-ChIP: Proteins were released from beads by 2x 15 min. incubation in 100 )l 
of buffer D shaking at 37°C. Elution was then diluted in ChIP buffer and ChIP 
performed as previously described.  
 
CHART-PCR: Cells were fixed as for ChIP, washed and collected in cold PBS, and 
counted. 1x106 cells were gently resuspended in 1 ml of MNase lysis buffer (10 mM 
Tris-HCl pH8, 10 mM NaCl, 3 mM MgCl2, 0.5% NP-40, 0.15 mM spermine, 0.5 mM 
spermidine) and incubated on ice for 5 min. followed by 10 min. 2 g centrifugation at 
4°C. Cells were resuspended in 1 ml of MNase digestion buffer (10 mM Tris-HCl pH 
8, 15 mM NaCl, 0.15 mM MgCl2, 60 mM KCl, 0.15 mM spermine, 0.5 mM 
spermidine, 2.5 mM CaCl2) and per each digestion reaction 100 )l were used. 
Digestion was carried out at room temperature with 3 unit of MNase (Roche) for 0, 1, 
5, 10 and 20 min. and reaction was stopped adding 100 )l of MNase STOP solution 
(10 mM EDTA, 2 mM EGTA, 2% SDS) and 20 U proteinase K. Protein digestion, 
decrosslinking and DNA isolation were performed as described in the ChIP chapter. 
DNA was analyzed by qPCR and its accessibility was assessed by comparing it to 
undigested DNA. 
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Primers. 
Locus Forward Reverse 
GAPDH CGTAGCTCAGGCCTCAAGAC GCTGCGGGCTCAATTTATAG 
IL1beta GTCTTCCACTTTGTCCCACA TGACAATCGTTGTGCAGTTG 
AlphaSATELLITE CTG CAC TAC CTG AAG AGG 
AC 
GAT GGT TCA ACA CTC TTA 
CA 
Chr17 -10 kb GAGCACAGCGCCACCA GCACAGCCCCTGCACA 
Chr17 -5 kb CCTCACGTGGCTGCCC CCTTCCTGCCAGGCTGC 
Chr17 -1 kb AGCCACCAGCCAACGG GAGGGCAAAGCGCCCA 
Chr17 peak kb GGGAAACTCTGCGCCACTAT CAGTGTCTCATGCTGGTGT 
Chr17 +1 kb TCCGATAGGCCGGTTTTGAC GGACGGAGTCTCTTCTCCCT 
Chr17 +5 kb GGAGGAACAGACAGGATGGC TTCCAGGGCAGGGACTATGA 
Chr17 +10 kb CTTCCACCTGGGAACCTGAG CCAGGAAGCAGGCTGATTGA 
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Fig. 1: The RFN146 WWE specifically pulls-down in vivo ADP-ribosylated 
proteins cross-linked to DNA.  
(a) Schematic overview of the ChAP workflow. (b) Western blotting analysis of 
ARTD1 and histones (i.e. H3) ADP-ribosylated in vitro and pulled down with wild-
type or mutant WWE and Af1521. The original image was edited by removing 1 lane. 
(c) Western blotting analysis of PAR and ARTD1 using chromatin prepared for ChAP 
as described in M&M from A549 cells untreated or treated with H2O2 and/or ABT-
888, inhibitor of ADP-ribosylation, and enriched by ChAP with WWE. (d) qPCR 
analysis of GAPDH TSS, IL1! promoter and !SAT of material enriched as in (c). (e) 
qPCR analysis of shMock and shARTD1 cells stimulated with H2O2 and/or ABT-888 
and analyzed as in (d). (f,g) qPCR analysis of formaldehyde-fixed extracts from cells 
treated with H2O2 and enriched by ARTD1 (f) or histone H3 (g) ChIP or ChAP-ChIP. 
(h) CHART-PCR of cells treated with H2O2 and/or ABT-888. 
 
Fig. 2: ADP-ribosylated proteins peak at DNA repetitive sequences.  
(a) Genome browser screen shot of a representative ADP-ribose peak (ID 12536) over 
a repetitive sequence. (b) Number of unique reads sequenced per each sample. (c) 
Average peak length of H2O2 treated sample. (d) qPCR analysis of the region 
surrounding peak ID 12536 using formaldehyde-fixed extracts from A549 cells 
treated with H2O2 and/or ABT-888 and enriched by ChAP with Af1521. (e) 
Distribution of H2O2 peaks relative to the closest gene. (f) Percentage of H2O2 peaks 
overlapping with repetitive sequences. 
 
 
Fig. 3: ADP-ribosylated proteins localize at the PRRE of a subset of PPAR" 
target genes.  
(a) Western blotting analysis of PAR, ARTD1 and histone H3 using formaldehyde-
fixed extracts from undifferentiated (d0) or differentiated (d7) enriched by ChAP with 
WWE. (b) qPCR analysis on the PRRE of PPAR! target genes AP2, Adiponectin and 
CD36 and on K19 promoter of material enriched as in (a), 12h ABT-888 inhibited 
cells were included in the analysis. (c) ARTD1 and PPAR! occupancy on AP2 and 
CD36 PRRE at d0 and d7. (d) qPCR analysis of ChIP and ChAP-ChIP of ARTD1 and 
PPAR! on AP2 and CD36 PRRE at d7. 
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Supplementary Fig. 1: the RNF146 WWE domain recognizes poly- but not 
mono-ADP-ribosylated proteins. 
(a,b) Autoradiography and coomassie staining of ARTD1 (a) or ARTD10 (b) in vitro 
modified in the presence of 100 nM 32PNAD+ and incubated with wild-type (wt) GST-
WWE, or with the iso-ADP-r binding deficient mutant R163A or the binding 
proficient mutant R161A; protein complexes were then resolved on SDS page and 
exposed on X-ray film. (c) Autoradiography and coomassie staining of ARTD1, 
ARTD2 and ARTD10 auto-ADP-ribosylated in vitro in the presence of 100 )M 
32PNAD+ and enriched with GST-WWE as in (a). 
 
Supplementary Fig. 2: 1 mM H2O2 treatment for 10’ does not impair cell 
viability or growth and fixation with 4% formaldehyde prevents PAR 
degradation and artifact generation.  
(a) Cell count of 24h or 48h post 10’ H2O2 treatment followed by recovery. Cells 
were treated when sub-confluent (left) of confluent (right). (b) PAR 
immunofluorescence (red) of cells left untreated or H2O2-treated and fixed in 
methanol:acetic acid (MeOH), 1% or 4% formaldehyde (Form.). DAPI (blue) was 
used as nuclear staining. (c) ARTD1 western blotting analysis of untreated and not-
fixed A549 cells lysed in lysis buffer (left) or lysis buffer containing ADP-
ribosylation inhibitor (PJ34, right). Protein extracts were enriched with WWE-
domain. (d) PAR and ARTD1 western blotting analysis of cells left untreated or 
treated with H2O2 and/or ABT-888 and processed for ChAP. 
 
Supplementary Fig. 3: The Af1521 macrodomain specifically enriches in vivo 
ADP-ribosylated cross-linked chromatin. 
(a) Western blotting analysis of PAR and ARTD1 using chromatin prepared for 
ChAP as described in M&M from A549 cells treated with H2O2 and enriched by 
ChAP with WWE or Af1521. (b-d) ChIP analysis of histone H3 (a), ARTD1 (b), 3 
histone H3 modifications (c) at GAPDH TSS, IL1! promoter and on !SAT regions. 
(e) ChAP analysis of GAPDH TSS, IL1! promoter and !SAT of material enriched as 
in (a). 
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Supplementary Fig. 4: Anti-PAR antibodies are not suitable for ChIP under the 
tested conditions. 
(a,b) qPCR analysis using chromatin prepared for ChAP as described in M&M from 
A549 cells treated with H2O2 and/or ABT-888 and enriched by ChIP with 10H (a) or 
a polyclonal anti-PAR antibody (b). 
  
Supplementary Fig. 5: H2O2-induced chromatin ADP-ribosylation is reversible 
and PAR-ChAP signal intensity depends on the H2O2 concentration 
(a) qPCR analysis using chromatin prepared for ChAP as described in M&M from 
A549 cells left untreated (-), treated for 10’ with H2O2, treated for 10’ with H2O2 and 
let recover for additional 20’ (30’) or for additional 80’ (90’) and then enriched by 
ChAP with WWE. (b) qPCR analysis using chromatin prepared for ChAP as 
described in M&M from A549 cells left untreated (-) or treated for 10’ with 0.2 mM 
or 1 mM H2O2.  
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 Unpublished results 3.3
3.3.1 H2O2-induced ADP-ribosylation does not change chromatin composition 
and is associated with constitutive heterochromatin 
Since heavily auto-ADP-ribosylated ARTD1 or trans-modified nucleosomes have 
been shown to be evicted from chromatin, we sought to assess whether H2O2-induced 
ADP-ribosylation provoked ARTD1 or nucleosome eviction from the 
chromatin25,141,142. We therefore induced nuclear ADP-ribosylation by treating A549 
cells with H2O2 or prevented it by treating cells with ABT-888 and subsequently 
performed ChIP analysis for ARTD1 and nucleosome (i.e. histone H3) (Fig.4A,B). 
 
 
 
Figure 4: H2O2-induced ADP-ribosylation does not change the chromatin composition. 
(A) ARTD1 ChIP analysis of A549 upon stimulation with 1mM H2O2 for 10min. ADP-ribosylation 
inhibited samples were pre-incubated for 30min with 1)M ABT-888. Values of GAPDH promoter, 
IL1" promoter and !-SAT regions are shown. (B) Histone H3 ChIP analysis as in (A). (C-E) ChIP 
analysis on histone modification of untreated cells or after H2O2 treatment. 
 
ChIP experiments showed that, in the same tested regions as in the submitted 
manuscript, the density of ARTD1 and the nucleosome correlated. The higher the 
histone H3 signal (i.e. chromatin compaction), the more abundant was ARTD1 
(Fig.4A,B). In addition, although ADP-ribosylation was described to induce protein 
eviction from the chromatin, we did not observe any change in ARTD1 or histone H3 
occupancy independently whether cells were treated only with H2O2 or ABT-888 or 
in combination (Fig.4A,B). We then expanded the ChIP analysis for 3 histone 
modifications, including histone H3 acetylation (H3Ac), an open chromatin marker, 
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H3K27me3, a facultative heterochromatin marker, and histone H3 lysine 9 tri-
methylation (H3K9me3), a constitutive heterochromatin marker (Fig.4C-E). The ChIP 
data revealed that the GAPDH promoter was enriched for H3Ac while the IL1? 
promoter and ?-SAT regions were both enriched for H3K9me3 (Fig.4C,E). In 
addition, H2O2 treatment did not alter the histone marks at the GAPDH or IL1" 
promoter indicating that H2O2-induced ADP-ribosylation does not change the 
nucleosome modification at these 2 promoters. In contrast, we observed a drop-down 
of H3K27me3 and H3K9me3 modifications after H2O2 treatment at the !-SAT 
regions, suggesting that the !-SAT regions may be more prone to regulation by ADP-
ribosylation upon H2O2 treatment than the other tested regions. Additional 
experiments are needed to mechanistically explain the effect of H2O2-induced ADP-
ribosylation at the !-SAT regions.  
To gain further insight into the histone modifications associated with ADP-
ribosylated chromatin, we treated A549 with H2O2 and enriched PARylated chromatin 
fragments by ChAP. We then released these fragments with SDS and performed ChIP 
(ChAP-ChIP) analysis for H3Ac, H3K27me3 and H3K9me3 (Fig.5A-C). 
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Figure 5: H2O2-induced poly-ADP-ribosylation preferentially associates with constitutive 
heterochromatin. 
(A) ChIP and ChAP-ChIP comparison of histone H3Ac after cell stimulation with H2O2. Values of 
GAPDH promoter, IL1" promoter and !-SAT regions are shown. Values are expressed as fold change 
over the ChIP signal arbitrarily set as 1. (B) ChIP and ChAP-ChIP comparison of histone H3K27me3 
as in (A). (C) ChIP and ChAP-ChIP comparison of histone H3K9me3 as in (A). (D-E) ChIP-ChAP 
analysis of the reported histone modifications at the GAPDH, IL1" promoter and !-SAT regions. 
Values are expressed as fold change over the signal of the mutant WWE domain arbitrarily set as 1. 
 
Our analysis showed that the ChAP-ChIP signals for histone H3Ac were lower than 
the ChIP signals for the tested regions, indicating that H2O2-induced PARylation and 
H3Ac are mutually exclusive (Fig.5A). Similar results were obtained when we 
analyzed H3K27me3, although we observed a positive correlation between 
PARylation and H3K27me3 at the !-SAT (Fig.5B). These data confirm that H2O2-
induced PARylation is differently regulated at the !-SAT regions compared to the 
GAPDH or IL1" promoter. In addition, we observed that H2O2-induced PARylation at 
the IL1" promoter and at the !-SAT regions was found with constitutive 
heterochromatic histone mark H3K9me3 (Fig.5C).  
To confirm these ChAP-ChIP data, we reversed the experiment and performed ChIP 
for histone H3, H3K27Ac, H3K27me3 or H3K9me3. We then released the fragments 
by SDS and performed a ChAP (ChIP-ChAP) analysis using either the wild-type (wt) 
or mutant (mut) WWE domain (Fig.5D-G). Our analysis revealed that histone H3 was 
associated with ADP-ribosylation at the IL1" promoter and at the !-SAT regions but 
not at the open GAPDH promoter, confirming that H2O2-induced chromatin 
H3Ac 
IgG 
* 
* 
* 
GAPDH
Ch
IP
Ch
AP
-C
hIP
0.0
0.5
1.0
1.5
Re
lat
ive
 e
nr
ich
m
en
t
ov
er
 C
hI
P
IL1!
Ch
IP
Ch
AP
-C
hIP
0.0
0.5
1.0
1.5
!SAT 
Ch
IP
Ch
AP
-C
hIP
0.0
0.5
1.0
1.5
H3K9me3 
IgG 
ND 
GAPDH
Ch
IP
Ch
AP
-C
hIP
0
10
20
30
Re
lat
ive
 e
nr
ich
m
en
t
ov
er
 C
hI
P
IL1!
Ch
IP
Ch
AP
-C
hIP
0
10
20
30
!SAT 
Ch
IP
Ch
AP
-C
hIP
0
10
20
30
H3K27me3 
IgG 
GAPDH
Ch
IP
Ch
AP
-C
hIP
0
1
2
3
20
40
60
80
Re
lat
ive
 e
nr
ich
m
en
t
ov
er
 C
hI
P
IL1!
Ch
IP
Ch
AP
-C
hIP
0
1
2
3
20
40
60
80
!SAT 
Ch
IP
Ch
AP
-C
hIP
0
1
2
3
20
40
60
80
A 
GAPDH 
IL1! 
"SAT 
H3_ChAP
wtmu
t wtmu
t wtmu
t0
5
10
15
Fo
ld 
ch
an
ge
 o
ve
r W
W
E-
m
ut
H3K27Ac_ChAP
wtmu
t wtmu
t wtmu
t0
5
10
15
H3K9me3_ChAP
wtmu
t wtmu
t wtmu
t0
5
10
15
H3K27me3_ChAP
wtmu
t wtmu
t wtmu
t0
5
10
15
WWE: 
B C 
D E F G 
 Results 
 69 
PARylation is associated with regions with high nucleosome content (Fig.5D). 
Conversely, no PAR signal was associated with H3K27Ac at any of the tested 
regions, in line with the notion that upon H2O2 treatment PARylation and histone H3 
acetylation are mutually exclusive (Fig.5E and A). We also observed that H2O2-
induced PARylation was associated with H3K27me3 and H3K9me3 at the !-SAT 
regions but not at GAPDH or IL1" promoter (Fig.5F and G), partially confirming the 
ChAP-ChIP results (Fig.5B,C). Overall our data indicate that upon H2O2 treatment 
PARylation is preferentially associated with constitutive heterochromatic regions and 
negatively correlates with histone H3 acetylation.  
3.3.2 H2O2 induced ADP-ribosylation or inhibition of ADP-ribosylation do not 
influence NF-!B-dependent gene expression  
Inhibitors of ADP-ribosylation have been shown to protect from eccessive 
inflammation and cell necrosis in response to cytokine overproduction121. In addition, 
ARTD1 has been linked to NF-"B target gene transcription, but it is still under debate 
whether ARTD1 enzymatic acticity is required or not64,143. Thus, we aimed at 
studying the effect of ADP-ribosylation on the transcription of NF-"B target genes. 
A549 epithelial cells were either treated with LPS alone, a compound known to 
activate NF-"B, in presence or absence of the ADP-ribosylation inhibitor ABT-888. 
Gene expression analysis revealed that 1h LPS treatment neither induced inducible 
nitric oxide synthase (iNOS), interferon gamma-induced protein 10 (IP10) nor 
interleukin 6 (IL6), 3 genes regulated by NF-"B, indicating that A549 cells are not 
sensitive to LPS treatment (Fig.6A).  
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Figure 6: H2O2-induced ADP-ribosylation or inhibition of ADP-ribosylation do not influence  
                 NF-!B-dependent gene expression in A549 cells. 
(A) Gene expression analysis of A549 upon stimulation with 1)g/ml LPS for 1h or 1mM H2O2 for 
10min followed by 20min recovery. ADP-ribosylation inhibited samples were pre-incubated for 30min 
with 1)M ABT-888. (B) Gene expression analysis of cells stimulated for 4h with 10ng/ml LPS or 
20ng/ml TNF# or 20ng/ml IL1$ or 5ng/ml PMA. ADP-ribosylation inhibited samples were pre-
incubated with 10)M ABT-888 30min before stimulation. (C) Gene expression analysis of A549 upon 
overnight stimulation with 10gn/ml IFN! followed by 2h 0.1)g/ml LPS or 40ng/ml TNF#. ADP-
ribosylation inhibited samples were pre-incubated with 1)M ABT-888 30min before LPS or TNF# 
stimulation. 
 
Repeating the experiment by replacing LPS with H2O2 revealed that also H2O2 does 
not induce NF-"B target gene transcription in these cells, although the same treatment 
induced PAR formation (Fig.6A). 
We then extended the analysis including other NF-"B-inducing stimuli such as LPS, 
tumor necrosis factor alpha (TNF#), interleukin 1 beta (IL1$) or phorbol 12-myristate 
13-acetate (PMA) and prolonged the treatment for 4h (Fig.6B). Cell treatment with 
LPS, TNF# or PMA did not induce IL1", IL6 or any detectable transcript across the #-
satellite (!-SAT) regions, whereas IL1$ promoted the transcription of IL1" and IL6 
but not of the !-SAT. This data show that only IL1$ treatment induced NF-"B in 
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A549 cells. Pretreatment of cells with ABT-888 did not alter IL1$-induced gene 
transcription suggesting that PARylation has no direct effect on IL1$-mediated NF-
"B-dependent gene expression (Fig.6B). 
To further test whether ADP-ribosylation could influence the transcription of pro-
inflammatory genes in A549 cells, we primed the cells with interferon gamma (IFN!) 
overnight, followed by NF-"B activation via LPS or TNF# treatment for 2h (Fig.6C). 
IFN! alone and in combination with LPS did not induce iNOS, IP10 or IL6 expression 
confirming that A549 are insensitive to LPS even when pretreated with IFN!. In 
contrast, IFN! combined with TNF# induced iNOS and IL6 but not IP-10 indicating 
that not all NF-"B target genes are transcribed upon stimulation with IFN! and TNF#. 
Nevertheless, also under these conditions, inhibition of ADP-ribosylation did not alter 
gene transcription (Fig.6C). 
In summary, our data indicate that ADP-ribosylation does not influence the 
transcription of NF-"B target genes under the tested conditions in A549 cells. 
 
  
 Discussion and Perspectives 
 72 
 
4 Discussion and Perspectives 
 ARTD1-mediated PARylation drives iPS cells reprogramming by 4.1
enhancing SOX2 recruitment to its target gene Fgf4  
In the published work we reported that ARTD1 and PARylation regulate fibroblasts 
to iPSC reprogramming at an early stage. In addition, we have mechanistically shown 
that ARTD1 PARylates SOX2 to enhance its recruitment to SOX2-binding sites on 
target genes and thus drive gene transcription. Among the regulated SOX2 target 
genes, we identified Fgf4 as key regulator of iPSC reprogramming. Indeed, early 
administration of exogenous FGF4 protein into the medium of ARTD1-/- or ADP-
ribosylation inhibited fibroblasts restored the reprograming efficiency to the levels 
observed for wild-type cells. In summary, the collaboration with the laboratory of Dr. 
Cinelli has mechanistically linked ARTD1 and PARylation to an efficient 
reprogramming of fibroblast to iPS cells. This part of my thesis thus extends our 
knowledge of iPSC reprogramming, a process of great relevance in regenerative 
medicine. 
PAR has been described to regulate the recruitment of transcription factors to their 
regulatory element in actively transcribed genes. For example, it has been shown that 
PAR functions on PPAR! target genes as a cage to enhance PPAR! ligand binding 
and cofactor exchange during adipogenesis138. Similarly, ARTD1 has been reported to 
promote the NFAT-mediated transcription of interleukin 2 by ADP-ribosylating 
NFAT DNA-binding domain and increasing its avidity for the DNA, 144. Thus it 
seems that PAR supports gene transcription through different mechanisms that are 
dependent on the context and on the signaling that induced PAR formation. For 
example, ADP-ribosylation is generated both in response to stress stimuli and as a 
consequence of more physiological processes such as adipogenesis. The different 
natures of the initial stimulus must be then mirrored on the chromatin-associated 
PAR, and on its mechanism of action.    
Upon transduction of somatic cells with the Yamanaka factors, cells undergo 
extensive chromatic and epigenetic changes to reset their cell-identity and to acquire 
stemness145,146. In this process, SOX2 is a key transcription factor that cooperates with 
the octamer-binding transcription factor 4 (OCT4) to induce the expression of 
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pluripotent genes, leading to the formation of pluripotent stem cells147. However, 
somatic cell-reprograming with the Yamanaka factors is currently a very inefficient 
process and the mechanisms that promote and sustain the expression of pluripotent 
genes are yet poorly understood147,148. Although no previous study has reported a 
functional contribution of ARTD1 and PARylation for SOX2-induced iPSC 
reprogramming, two recent studies have reported that ARTD1 and PARylation 
influence SOX2 in embryonic stem cells (ES cells)76,149. In particular, Gao and 
colleagues showed that in ES cells SOX2 represses Fgf4 transcription by binding to 
Fgf4-enhancer and that ARTD1 ADP-ribosylates SOX2 to induce its eviction from 
the Fgf4-enhancer subsequently promoting Fgf4-gene transcription76. Conversely, in 
the second study, Lai and colleagues have shown that during retinoic acid-induced ES 
cells differentiation to neuronal precursors, ARTD1 PARylates itself but not SOX2149. 
Modified ARTD1 formed a complex with SOX2 to prevent SOX2 from binding to 
Sox2/Oct4-binding sites and repressed gene transcription149. Differences in the 
chromatin composition or in the signaling cascade may account for the divergent 
mechanisms of ARTD1 observed in reprogramming fibroblast or ESCs. In addition, 
to assess the role of ADP-ribosylation on gene transcription, both Gao et al. and Lai et 
al. used PJ34, a second generation inhibitor of ADP-ribosylation known to 
unspecifically target Pim1 and Pim2, 2 serine/threonine kinases that modulate gene 
transcription126. Therefore, PJ34 treatment may have induced changes in gene 
expression that were independent or only partially dependent on ADP-ribosylation 
inhibition. Instead, we characterized the effect of ARTD1 activity on gene 
transcription by treating the cells with ABT-888 a third generation and more specific  
inhibitor, limiting possible off-target effects150. Unfortunately, the lack of a specific 
anti-PAR antibody suitable for ChIP prevented us from showing that PAR is present 
at the Fgf4-enhancer together with SOX2. In fact, we cannot exclude that ARTD1 and 
PAR regulate SOX2 retention indirectly, without being physically associated with the 
Fgf4-enhancer. For example, ARTD1 and PARylated SOX2 may regulate the 
expression of genes other than Fgf4, whose protein products may be involved in 
recruiting SOX2 to Fgf4-enhancer in a PAR independent fashion. Thus, further ChIP 
analysis of ARTD1 and ChAP (see next paragraph) are needed to unequivocally 
prove the role of PAR in keeping SOX2 recruited to the Fgf4-enhancer. In addition, 
although we provided very strong evidence that SOX2 is ADP-ribosylated, SOX2 
mutagenesis experiments are needed to elucidate what residues and domains are 
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targeted by PARylation and how this influences SOX2 properties. Moreover, it 
remains to be elucidated by which process the enzymatic activity of ARTD1 is 
induced during reprogramming. Interestingly, Lai and colleagues showed that the 
treatment of ESCs with exogenous FGF4 activated the FGF/ERK-signaling pathway 
leading to ARTD1 activation149. In fibroblast, Fgf4 is not expressed and cannot be 
responsible for the activation of ARTD1151. However, we showed that Fgf4 is 
transcribed in the initial phase of reprograming and that FGF4 induces fibroblast 
growth factor receptor (FGFR) signaling to promote iPS colony formation. Therefore, 
it would be interesting to address the effect of FGF4 signaling on ARTD1 activity. In 
this regard, Thomas et al. have recently shown that the Drosophila tandem kinase 
JIL1 phosphorylates histone H2Av at serine 137 to activate ARTD1 enzymatic 
activity65. JIL1 is the Drosophila orthologous of the mammalian mitogen- and stress-
activated protein kinase 1 (MSK1) which, in response to mitogens signaling (e.g. 
FGF/ERK), phosphorylates serine 10 on histone H3 (H3S10ph) and other chromatin-
associated proteins to promote gene transcription152,153. MSK1 activated by the FGF4 
signaling in reprogrammed fibroblasts, might thus phosphorylate histone H3 serine 10 
to subsequently activate ARTD1-mediated PAR-formation. If so, inhibition of the 
FGF/ERK-signaling or MSK1 depletion by siRNA should reduce reprograming-
induced PAR formation and SOX2-dependent gene transcription. Comparing the 
transcriptomes of MSK1-depleted cells with ARTD1-/- cells would define the target 
genes that are simultaneously regulated by MSK1-signaling and PARylation. 
Furthermore, confirming the phosphorylation of histone H3S10 by ChIP analysis for 
these target genes would point at an interplay between such histone modification and 
PARylation. 
Another recent study has shown that at early stage of reprogramming, ARTD1 and the 
ten-eleven translocation-2 (Tet2) cooperate to erase the DNA methylation at the 
pluripotent genes Nanog and Esrrb and promote their accessibility for the pluripotent 
transcription factor OCT4154. The authors describe a mere correlation between 
ARTD1 deficiency and 5-methyl cytosine (5meC) levels at these two pluripotent gene 
promoters, without providing further mechanistic insights. In addition, it is not clear 
whether ARTD1 enzymatic activity is necessary for 5meC erasure at these genomic 
sites. It remains open whether the ARTD1-mediated Fgf4 transcriptional regulation 
described by our group is connected with ARTD1-mediated 5meC reduction. 5meC 
analysis of the Fgf4 promoter and of the two analyzed Nanog and Esrrb promoters in 
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ARTD1-/- fibroblasts reprogramming would provide additional evidence whether 
demethylation can also be observed at other sites and whether demethylation is 
regulated by ARTD1. Moreover, complementation of these experiments with 
exogenous FGF4 would help to address whether FGF-signaling is responsible for 
erasing 5meC at Nanog and Esrrb promoters and for increasing OCT4 recruitment to 
these sites.  
Our study raises some additional open questions that are worth to investigate. ARTD1 
and its enzymatic activity might also influence additional processes later during iPSC 
generation. Given that ARTD1 and ADP-ribosylation regulate cell cycle at several 
steps146 and considering the importance of cell proliferation in reprograming147, it 
would be very interesting to study whether ARTD1 ablation or inhibition of ADP-
ribosylation lead to additional changes in cell proliferation or cell cycling during the 
early-mid phases of reprograming155,156. Indeed, although Doege et al. have shown 
that ARTD1 overexpression does not alter cell proliferation in reprogramming cells, 
as measured by Br-dU incorporation, the effects of ARTD1 ablation or inhibition on 
cell proliferation has not yet been meticulously studied154.  
As ADP-ribosylation inhibited fibroblasts generate fewer iPS colonies when 
compared to ARTD1-/- fibroblasts, ARTD1 may not be the only ARTD generating 
PAR that contributes to fibroblast reprogramming. This could be addressed by 
quantifying whether ARTD1-/- fibroblasts treated with ADP-ribosylation inhibitor 
generate fewer iPS colonies than ARTD1-/- fibroblast. In particular, nuclear ARTD2 
and its activity may directly contribute to chromatin remodeling157. Furthermore, 
ARTD5 or 6, as cytoplasm/nucleus shuttling poly-ARTDs, may be implicated in the 
cell signaling that leads to reprogramming and have an indirect effect on this 
process158-160. Thus, performing a siRNA screening including the above mentioned 
ARTDs and combining it with ChIP and gene expression analysis would help define 
the contribution of each member. In addition, while we have addressed the 
contribution of ARTD1-induced PARylation in reprograming, the role of protein 
MARylation needs still to be elucidated and additional efforts in this direction may 
reveal a far more complex network of modifications.  
Cell reprogramming is emerging as a promising field in regenerative medicine. In 
order to redefine its identity, a somatic cell has to overcome some epigenetic barriers 
and express genes that in somatic cells are usually silenced. Here, we have reported 
that ARTD1-mediated ADP-ribosylation is part of the complex mechanisms that lead 
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to fibroblasts reprogramming. A complete understanding of the signaling that 
activates ARTD1 and promotes SOX2 ADP-ribosylation may lead to changes in the 
strategy currently used to generate iPS cells. For example, linking ADP-ribosylation 
to a specific signaling pathway may provide a way to activate ARTD1 in a temporal 
specific manner and increase the reprograming efficiency. In addition, an intriguing 
possibility is that ARTD1 over-expression or its targeted activation may replace one 
or more of the Yamanaka oncogenic factors limiting the risk of tumorigenesis. 
Furthermore, as ADP-ribosylation has been implicated in both reprogramming and 
cell differentiation, changing the pattern of ADP-ribosylation in a somatic cell, 
through a combination of PAR-inducing stimuli, may favor transdifferentiation 
bypassing the need for a pluripotent intermediate. 
 ADP-ribose binders as tools to investigate chromatin-associated 4.2
protein ADP-ribosylation 
In this second part of my thesis I describe a novel chromatin affinity precipitation 
(ChAP) method that allows to further analyze the nuclear dynamics of chromatin 
ADP-ribosylation. By applying this method to investigate H2O2-mediated ADP-
ribosylation we have showed that it preferentially localized to nucleosome-dense and 
heterochromatic regions and to repetitive elements within the genomic DNA. 
Conversely, during adipogenesis, ADP-ribosylation was associated with PPAR! on 
PPAR! target genes confirming some previous finding of our laboratory92.  
In vitro observations have indicated that ARTD1-mediated PARylation of histones 
and other chromatin-associated proteins increase their negative charge repelling them 
from the DNA and inducing chromatin de-compaction161. In vivo studies on the hsp70 
promoter in the salivary glands of Drosophila confirmed that ARTD1 auto-
modification and trans-ADP-ribosylation of histones induces chromatin loosening and 
puff formation to enhance hsp90 gene transcription162. A similar mechanism has also 
been reported to regulate a subset of NF-"B target genes in murine macrophages, 
although ADP-ribosylation in this study might have been induced during cell lyses 64. 
Our data indicated that H2O2-induced ADP-ribosylation did not provoke ARTD1 or 
nucleosome eviction, but increased the accessibility to the DNA in the chromatin 
context. 
To study protein and protein-PTM localization on the genome, ChIP is the most 
commonly used technique in molecular biology. For studying chromatin-associated 
 Discussion and Perspectives 
 77 
ADP-ribosylation, this approach has been limited by the lack of ChIP-specific 
antibodies. Indeed, 10H, the most common anti-PAR antibody, showed unspecific 
binding to chromatin when used for ChIP, possibly due to the repulsion of proteins 
from chromatin due to long PAR-chains, the epitopes of 10H antibody55,57. Similar 
results were obtained with another commercially available polyclonal anti-PAR 
antibody, suggesting that anti-PAR antibodies are not suitable for ChIP under the 
tested conditions. Therefore, we functionally replaced the anti-PAR antibody with a 
GST-tagged WWE domain, a domain with high affinity for iso-ADP-ribose, the 
smallest PAR structure, and developed a ChAP method for enriching endogenously 
ADP-ribosylated proteins in the chromatin context. A similar strategy has been 
already applied in two previous studies where the authors used the macrodomain 
Af1521, an ADP-ribose binder that recognize both MARylated and PARylated 
proteins, combined with mass spectrometry (MS) to identify ADP-ribosylated 
proteins non fixed to chromatin 57,58. While in the first study Dani et al. identified only 
few proteins to be ADP-ribosylated in untreated cells, Jungmichel et al. expanded the 
analysis by treating HeLa cells with different genotoxic stimuli, which led to the 
identification of 235 ADP-ribosylated proteins57,58. Most of the identified proteins 
localized to the nucleus and were involved in DNA and RNA metabolism. However, 
due to the cell lysis, none of the above studies addressed the ADP-ribosylation of 
chromatin-associated proteins. Moreover, very little is known about the localization 
of ADP-ribosylated chromatin-associated proteins within the nucleus. For example, 
heavy PARylation of ARTD1 or nucleosomes has been reported to repulse proteins 
from the chromatin, whereas some transcription factors, once PARylated, increase 
their affinity for the DNA64-66,138,139. Our ChAP data indicate that, after induction of 
protein ADP-ribosylation by H2O2, the modified proteins remain associated with the 
DNA, under the testes condition. However, we cannot exclude that the extent of 
ADP-ribosylation might differ between the modified proteins and that only proteins 
modified with short PAR could be detected by ChAP whereas heavily modified 
proteins were repulsed from the chromatin. Alternatively, the PAR glycohydrolase 
(PARG) and other PAR-degrading enzymes may counteract ARTD1 activation and 
keep the PAR length below a certain length preventing proteins from being evicted 
from DNA and allowing the detection of the whole chromatin-associated ADP-
ribosylome25. 
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Our genome-wide analysis of ADP-ribosylated protein revealed that H2O2 induced 
chromatin ADP-ribosylation is not randomly distributed but rather targeted to 
repetitive sequences such as LINEs, SINEs and #-satellites in intergenic regions or in 
introns but not in exons. These results indicate that there is a local discrimination in 
the chromatin that prevents coding sequences from being ADP-ribosylated and favors 
instead latent sequences. How this discrimination is established remains so far 
unknown. One possibility is that ARTD1 is more enriched at repetitive sequences 
(compared to transcriptionally active sequences) and therefore these regions are more 
prone to be ADP-ribosylated in response to H2O2. A genome-wide profiling of 
ARTD1 occupancy by ChIP-Seq would help to understand whether ARTD1 and the 
herein detected PARylated protein peaks overlap. Unfortunately, all so far available 
genome-wide ARTD1 analyses focused on promoter regions68,163. In line with that, 
another open question is, what regulates the recruitment of ARTD1 to the chromatin. 
Although some reports claimed to have identified an ARTD1 DNA-consensus 
sequence, more studies are needed to validate these findings164. A sequence and 
structural analysis of the genomic loci associated with PARylated domains may reveal 
common features that may be involved in ARTD1 recruitment. Indeed, it has been 
reported that ARTD1 has binding preferences for structured DNA165. In addition, as 
we provide evidence that ARTD1 occupancy strongly correlates with histone H3 
occupancy, nucleosomes might be a docking platform for ARTD1 (see below). Thus, 
ChIP and ChAP-ChIP analysis of ARTD1, nucleosome, histone variants and histone 
modifications at the identified ADP-ribosylated chromatin regions would help to 
define the chromatin context necessary to bind and activate ARTD1 in response to 
H2O2. In addition, defining whether ADP-ribosylated repetitive elements are 
associated with transcribed genes and whether they generate transcripts may help to 
address any involvement of RNA in ARTD1 activation. 
The observation that protein ADP-ribosylation preferentially localized at nucleosome 
dense regions and repetitive sequences was surprising, as H2O2 induced ADP-
ribosylation was thought to occur mainly on open chromatin, as it should be more 
exposed to DNA oxidation129. This may indicate that H2O2 induces DNA damage not 
randomly but mainly at genomic loci with high nucleosome content and repetitive 
elements where ARTD1 is then activated to initiate DNA repair. Extensive DNA 
damage is known to induce an over-production of ADP-ribosylation that depletes the 
cellular ATP pool and induces cell death by necrosis166. In this context, chromatin 
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ADP-ribosylation may then be a temporary storage of intracellular energy in a form 
that can be reused by the subsequent action of PARG and ADP-ribose 
pyrophosphorylase to regenerate ATP167. However, by doing so, the ADP-ribosylated 
chromatin regions become more accessible and potentially more exposed to 
mutagenesis, which is the down side of this process. Therefore, targeting ADP-
ribosylation to chromatin with repetitive DNA sequences may be an elegant way 
exploited by the cell to store energy at non-expressed genomic regions preventing 
coding regions, regulatory elements and non-coding RNAs from being exposed and 
harmed by possible mutations.  
Our laboratory recently published that during differentiation of 3T3L1 to adipocytes, 
topoisomerase II activity induces ARTD1-auto-modification and thereby sustains 
PPAR! target genes transcription92. Our newly developed ChAP method allowed us 
to enrich chromatin fragments ADP-ribosylated during adipogenesis and to confirm 
that ADP-ribosylation regulates PPAR! target-genes in a way similar to what happens 
during reprogramming at SOX2 target-genes. ARTD1 generates PAR to keep PPAR! 
in close proximity to its DNA response elements, preventing it from dissociating from 
the DNA and thus increasing PPAR!-dependent gene transcription.  
Together, the newly developed ChAP method represents a powerful tool to study the 
interplay between ADP-ribosylation and other histone modifications in the chromatin 
context in different cell types. The interplay will most likely define how ADP-
ribosylation is induced and how it influences the chromatin structure and the 
functional implications in chromatin remodeling, DNA repair or gene transcription. 
Within a certain cellular process, the ChAP technique will help researchers to 
discriminate between those genomic loci or genes that are directly regulated by ADP-
ribosylation and those that are indirectly affected, a discrimination that is not evident 
by using ADP-ribosylation inhibitors. Given the great medical relevance of ADP-
ribosylation inhibitors in the treatment of certain cancers, in modulating inflammation 
and in cellular reprogramming, the ChAP method will provide scientists with a tool to 
further dissect the molecular mechanisms underlying the promising effects of ADP-
ribosylation inhibitors. 
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 Effect of ADP-ribosylation inhibitors on NF-!B-dependent gene 4.3
expression 
One of the aims of this thesis was to define the contribution of ADP-ribosylation on 
NF-"B activation and target gene transcription. Since previous studies showed that 
inhibition of ADP-ribosylation had a beneficial effect on LPS-induced endotoxic 
shock in mice, and since ARTD1 has been implicated in NF-"B target gene 
transcription, we hypothesized that ADP-ribosylation might directly contribute to NF-
"B-induced gene activation168,169. However, when we induced NF-"B in A549 cell 
with pro-inflammatory compounds, we did not observe any effect of PARylation on 
gene transcription, although only IL1$ and IFN! combined with TNF# were able to 
successfully induce NF-"B-dependent gene expression. Similar data were obtained in 
a macrophage cell line (personal communication of Dr Minotti) in our laboratory, 
suggesting that either PARylation does not affect NF-"B target gene transcription or 
that it regulates other NF-"B target genes not taken in account in our analysis, or that 
the beneficial effect of the ADP-ribosylation inhibitors during inflammation in vivo is 
due to inhibition of ARTD-members that are not inhibited by ABT-888170. In our 
analysis we restricted the cell stimulation to a single NF-"B-activating compound 
whereas in vivo cells are exposed to a number of pro-inflammatory stimuli that may 
account for the activation of ADP-ribosylation. In addition, the in vivo generation of 
ADP-ribosylation may not be due to NF-"B activation, but rather due to cellular stress 
as side effect, for example, of high body temperature or cell exposure to toxic 
molecules released by other necrotic cells. Expanding the analysis using a 
combination of several pro-inflammatory compounds and different temperature and 
performing a deep-sequencing RNA analysis on stimulated cells may reveal the 
molecular mechanisms underlying the beneficial effects of inhibition of ADP-
ribosylation during inflammation.  
To address the mechanisms underlying the beneficial role of ADP-ribosylation 
inhibition in animals challenged with pro-inflammatory stimuli, in vitro models may 
nor represent a good option. A systematic approach in animal models is necessary to 
address the molecular effect of ADP-ribosylation during acute or chronic 
inflammation. In addition it may be useful to develop a rapid and automated “in cell” 
sensor that can be used to detect the formation of ADP-ribosylation. In this way 
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different treatments could be tested to address what combinations of factors are 
indeed responsible for the formation of ADP-ribosylation in cells.  
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